ATP5IF1 (also known as IF1 or ATPIF1) encodes the mitochondrial ATPase inhibitor, a small nuclear-encoded protein that reversibly inhibits the F1Fo-ATP synthase (complex V) to prevent wasteful ATP hydrolysis when the mitochondrial membrane potential collapses (e.g., during ischemia or hypoxia). IF1 is active as an antiparallel dimer at acidic pH (<6.7) and inactive as a tetramer at neutral pH. The N-terminal inhibitory region (residues 26-52) binds the alpha/beta catalytic interface of the F1 domain and contacts the gamma subunit to block rotary catalysis. IF1 also binds the OSCP subunit, which protects cancer cells from permeability transition pore-dependent apoptosis. Phosphorylation at Ser39 by a mitochondrial PKA-like activity inactivates IF1. The protein is overexpressed in many cancers and contributes to the glycolytic Warburg phenotype. IF1 also indirectly regulates heme synthesis in erythroid tissues and promotes ATP synthase dimerization, which influences cristae morphology.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0005737
cytoplasm
|
IBA
GO_REF:0000033 |
REMOVE |
Summary: IBA annotation for cytoplasm based on phylogenetic inference. While IF1 is primarily a mitochondrial matrix protein, the precursor form is synthesized in the cytoplasm before import. The IBA also includes plant orthologs (TAIR locus) and bovine P01096, suggesting broad conservation. However, cytoplasm is a very general CC term and the primary active localization of IF1 is mitochondrial.
Reason: The GOA qualifier is is_active_in, and the available evidence supports cytosolic synthesis/import transit rather than ATP5IF1 being active in cytoplasm. The functional location of IF1 is mitochondrial, especially the matrix-facing F1Fo-ATP synthase context.
Supporting Evidence:
PMID:10664857
cDNA coding the human homolog of the inhibitor protein was isolated and sequenced
|
|
GO:0005739
mitochondrion
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: IBA annotation for mitochondrion based on phylogenetic inference across the ATPase inhibitor family. This is the primary active localization of IF1.
Reason: Mitochondrial localization is the core cellular compartment for IF1. The mature protein functions in the mitochondrial matrix where it binds the F1 catalytic domain of ATP synthase. This is supported by multiple experimental studies (PMID:12110673, PMID:35926043) and UniProt annotation.
Supporting Evidence:
PMID:12110673
IF(1) could be co-isolated with F(1)F(0) when the immunocapture procedure was carried out at pH 6.5 but was absent when the ATP synthase was isolated at pH 8.0
|
|
GO:0006783
heme biosynthetic process
|
IBA
GO_REF:0000033 |
KEEP AS NON CORE |
Summary: IBA annotation for heme biosynthetic process based on phylogenetic inference from mouse (MGI:1196457) and zebrafish (ZFIN:ZDB-GENE-070410-36) orthologs. Shah et al. (2012, PMID:23135403) demonstrated that Atpif1 regulates heme synthesis in developing erythroblasts by modulating mitochondrial pH and redox potential, allowing FECH to catalyze iron incorporation into protoporphyrin IX.
Reason: This is a genuine but indirect role of IF1. The protein does not directly participate in heme biosynthetic enzymology; rather, by inhibiting ATP hydrolysis, IF1 maintains mitochondrial pH and redox conditions favorable for FECH activity. UniProt explicitly states: "Indirectly acts as a regulator of heme synthesis in erythroid tissues: regulates heme synthesis by modulating the mitochondrial pH and redox potential, allowing FECH to efficiently catalyze the incorporation of iron into protoporphyrin IX to produce heme" (PMID:23135403). This is a secondary consequence of its primary ATPase inhibitor activity, relevant mainly in erythroid tissues.
Supporting Evidence:
PMID:23135403
Mitochondrial Atpif1 regulates haem synthesis in developing erythroblasts
|
|
GO:0030218
erythrocyte differentiation
|
IBA
GO_REF:0000033 |
KEEP AS NON CORE |
Summary: IBA annotation for erythrocyte differentiation based on phylogenetic inference from mouse and zebrafish orthologs. The evidence comes from PMID:23135403 showing that Atpif1 is required for proper heme synthesis during erythroid development.
Reason: Like heme biosynthesis, erythrocyte differentiation is an indirect downstream consequence of IF1's ATPase inhibitor activity. IF1 is not an erythroid-specific transcription factor or signaling molecule; it supports erythropoiesis by maintaining mitochondrial conditions needed for heme synthesis. This represents a tissue-specific pleiotropic effect rather than a core molecular function.
Supporting Evidence:
PMID:23135403
Mitochondrial Atpif1 regulates haem synthesis in developing erythroblasts
|
|
GO:0042030
ATPase inhibitor activity
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: IBA annotation for ATPase inhibitor activity based on phylogenetic inference across the ATPase inhibitor family (bovine P01096, rat RGD:2181, and human Q9UII2). This is the defining molecular function of IF1.
Reason: ATPase inhibitor activity is the core molecular function of ATP5IF1. The protein is named for this activity and belongs to the ATPase inhibitor family. IF1 inhibits the ATP hydrolase activity of F1Fo-ATP synthase, preventing wasteful ATP consumption when the proton gradient collapses (PMID:12110673, PMID:15528193, PMID:24005319). The IBA correctly reflects the conserved function across mammals.
Supporting Evidence:
PMID:12110673
The captured complex V displayed ATP hydrolysis activity that was fully oligomycin and inhibitor protein IF(1)-sensitive
PMID:15528193
IF1 protein bound to purified F(1) ATP synthase and inhibited F(1)-dependent ATP hydrolysis consistent with its reported activity in studies of mitochondria
file:human/ATP5IF1/ATP5IF1-deep-research-falcon.md
IF1 is a reversible, pH-sensitive inhibitor that primarily prevents wasteful ATP hydrolysis when Δψm collapses, but can also inhibit ATP synthesis in some contexts
|
|
GO:0051117
ATPase binding
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: IBA annotation for ATPase binding based on phylogenetic inference. IF1 physically binds the F1 catalytic domain of ATP synthase, contacting the alpha/beta subunit interface and the gamma subunit.
Reason: ATPase binding is a core function that underlies the inhibitory activity of IF1. Structural and biochemical studies demonstrate direct binding to the F1 domain. The IBA annotation is consistent with the well-established mechanism of IF1 action. Aggeler et al. (PMID:12110673) showed IF1 co-isolates with F1Fo at pH 6.5, and UniProt documents the binding interface at the alpha-beta subunit interface (residues 26-52).
Supporting Evidence:
PMID:12110673
IF(1) could be co-isolated with F(1)F(0) when the immunocapture procedure was carried out at pH 6.5
|
|
GO:0005739
mitochondrion
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: IEA annotation for mitochondrion based on combined automated methods including InterPro domain (IPR007648) and UniProt subcellular location annotation. Consistent with all other evidence for mitochondrial localization.
Reason: This electronic annotation is consistent with the well-established mitochondrial localization of IF1, supported by multiple experimental evidence codes (IDA, HTP, HDA, ISS, TAS, IBA). The InterPro domain IPR007648 (ATPase_inhibitor_mt) is specifically a mitochondrial domain.
|
|
GO:0042030
ATPase inhibitor activity
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: IEA annotation for ATPase inhibitor activity based on InterPro domain IPR007648 mapping. This is the defining function of the protein family.
Reason: The InterPro-based electronic annotation correctly identifies the core molecular function. The ATPase_inhibitor_mt domain (IPR007648) is directly associated with ATPase inhibitor activity, and this is the primary function of IF1 supported by extensive experimental evidence.
|
|
GO:0005515
protein binding
|
IPI
PMID:28514442 Architecture of the human interactome defines protein commun... |
MODIFY |
Summary: IPI annotation for protein binding from the BioPlex 2.0 human interactome study (Huttlin et al. 2017). The WITH column indicates binding to P06576 (ATP5F1B, the beta subunit of F1-ATP synthase). This interaction is biologically meaningful and well-established.
Reason: While the interaction with ATP5F1B (beta subunit) is real and reflects the core mechanism of IF1, "protein binding" (GO:0005515) is uninformative. The specific interaction with the beta subunit of ATP synthase is the mechanistic basis of IF1's inhibitory function. A more specific term should be used.
Proposed replacements:
mitochondrial proton-transporting ATP synthase complex binding
Supporting Evidence:
PMID:28514442
Architecture of the human interactome defines protein communities and disease networks
|
|
GO:0005515
protein binding
|
IPI
PMID:30021884 Histone Interaction Landscapes Visualized by Crosslinking Ma... |
REMOVE |
Summary: IPI annotation for protein binding from a crosslinking mass spectrometry study of intact cell nuclei (Fasci et al. 2018). The WITH column indicates binding to P06576 (ATP5F1B). This study focused on histone interactions in nuclei, making ATP5IF1 detection likely a contaminant or crossreactive hit.
Reason: This intact-nuclei XL-MS study does not provide reliable support for a physiological mitochondrial ATP5IF1-ATP5F1B interaction. The core ATP synthase complex binding function is already supported by direct mitochondrial evidence from other publications, so this nuclear-context protein-binding row should not be modified into that term.
Supporting Evidence:
PMID:30021884
Histone Interaction Landscapes Visualized by Crosslinking Mass Spectrometry in Intact Cell Nuclei
|
|
GO:0005515
protein binding
|
IPI
PMID:32296183 A reference map of the human binary protein interactome. |
MARK AS OVER ANNOTATED |
Summary: IPI annotation for protein binding from the HuRI reference binary interactome map (Luck et al. 2020). The WITH column indicates binding to Q9HAQ2 (KIF9) and Q9NRD5 (PICK1). These are high-throughput Y2H hits with no clear biological relevance to IF1's known function.
Reason: KIF9 and PICK1 are not known to have any functional relationship with mitochondrial ATP synthase or IF1's inhibitory activity. These likely represent false-positive or non-physiological interactions from high-throughput Y2H screening. The generic "protein binding" term combined with HTP interactome partners of unclear relevance makes this an over-annotation.
Supporting Evidence:
PMID:32296183
A reference map of the human binary protein interactome
|
|
GO:0005515
protein binding
|
IPI
PMID:32807793 OSMR controls glioma stem cell respiration and confers resis... |
MARK AS OVER ANNOTATED |
Summary: IPI annotation for protein binding from Sharanek et al. 2020, studying mitochondrial OSMR in glioblastoma. The WITH column indicates binding to Q99650 (OSMR). The paper found OSMR localizes to mitochondria and interacts with complex I, and IF1 was detected as an interactor.
Reason: While OSMR was shown to localize to mitochondria, the interaction with IF1 is likely an indirect association within the mitochondrial inner membrane protein network rather than a direct functional interaction. The paper focuses on OSMR-complex I interactions, not IF1. The generic "protein binding" term does not capture any meaningful functional relationship.
Supporting Evidence:
PMID:32807793
OSMR controls glioma stem cell respiration and confers resistance of glioblastoma to ionizing radiation
|
|
GO:0005515
protein binding
|
IPI
PMID:32814053 Interactome Mapping Provides a Network of Neurodegenerative ... |
MARK AS OVER ANNOTATED |
Summary: IPI annotation for protein binding from a neurodegenerative disease interactome mapping study (Haenig et al. 2020). The WITH column lists many diverse proteins (PMP22, DMWD, NEFL, TOR1A, KLF11, DNAJB6, DNM2, FGFR3, GLE1, GRN, GSN, HRAS, A2M, ADRB2, MECP2, NUP58, SPRED1, P28329-3/CHAT, P28799-2/GRN). These represent high-throughput Y2H hits from a disease-focused interactome screen.
Reason: This is a large-scale interactome study focused on neurodegenerative disease proteins. The vast majority of these interactors (NEFL, MECP2, HRAS, FGFR3, GSN, A2M, etc.) have no plausible direct functional relationship with mitochondrial IF1. These are likely false positives or non-physiological interactions from Y2H. The sheer number and diversity of partners argues against specificity. "Protein binding" is already uninformative and these interactions do not add functional insight.
Supporting Evidence:
PMID:32814053
Interactome Mapping Provides a Network of Neurodegenerative Disease Proteins and Uncovers Widespread Protein Aggregation in Affected Brains
|
|
GO:0005515
protein binding
|
IPI
PMID:33961781 Dual proteome-scale networks reveal cell-specific remodeling... |
MODIFY |
Summary: IPI annotation for protein binding from BioPlex 3.0 (Huttlin et al. 2021). The WITH column indicates binding to P06576 (ATP5F1B, beta subunit of F1-ATP synthase). This is the same core interaction as PMID:28514442.
Reason: The interaction with ATP5F1B is the core functional binding partner of IF1 and is well-established. However, "protein binding" is uninformative. A more specific term should be used.
Proposed replacements:
mitochondrial proton-transporting ATP synthase complex binding
Supporting Evidence:
PMID:33961781
Dual proteome-scale networks reveal cell-specific remodeling of the human interactome
|
|
GO:0005515
protein binding
|
IPI
PMID:40205054 Multimodal cell maps as a foundation for structural and func... |
MODIFY |
Summary: IPI annotation for protein binding from Schaffer et al. 2025 multimodal cell maps study. The WITH column indicates binding to P06576 (ATP5F1B). Again, the same core interaction with the beta subunit.
Reason: Same rationale as for PMID:28514442 and PMID:33961781. The interaction with ATP5F1B is real but "protein binding" is uninformative. A more specific MF term exists.
Proposed replacements:
mitochondrial proton-transporting ATP synthase complex binding
Supporting Evidence:
PMID:40205054
Multimodal cell maps as a foundation for structural and functional genomics
|
|
GO:0006783
heme biosynthetic process
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: IEA annotation for heme biosynthetic process transferred from mouse ortholog O35143 via Ensembl Compara. Consistent with the IBA annotation and the experimental evidence from Shah et al. (PMID:23135403).
Reason: This electronic transfer from the mouse ortholog is consistent with the IBA annotation and PMID:23135403 showing IF1 regulates heme synthesis indirectly. Same rationale as the IBA annotation: this is a genuine but non-core function.
|
|
GO:0030218
erythrocyte differentiation
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: IEA annotation for erythrocyte differentiation transferred from mouse ortholog O35143 via Ensembl Compara. Consistent with the IBA annotation and PMID:23135403.
Reason: Same rationale as the IBA annotation for this term: erythrocyte differentiation is a tissue-specific downstream consequence of IF1's ATPase inhibitor activity supporting heme synthesis.
|
|
GO:0045732
positive regulation of protein catabolic process
|
IMP
PMID:24005319 Genome-wide RNAi screen identifies ATPase inhibitory factor ... |
KEEP AS NON CORE |
Summary: IMP annotation from Lefebvre et al. 2013 genome-wide RNAi screen that identified ATPIF1 as essential for PARK2 recruitment and mitophagy. ATPIF1 knockdown blocked PARK2-dependent ubiquitination and subsequent mitophagy of damaged mitochondria, which involves protein catabolism of ubiquitinated mitochondrial substrates.
Reason: The connection to protein catabolism is through the PINK1-PARK2 mitophagy pathway. ATPIF1 promotes mitochondrial depolarization during uncoupling, which triggers PARK2 recruitment and ubiquitination of mitochondrial proteins for proteasomal/autophagic degradation. This is an indirect downstream consequence of IF1's primary ATPase inhibitor activity. While experimentally demonstrated, it is not a core function.
Supporting Evidence:
PMID:24005319
we identified ATPase inhibitory factor 1 (ATPIF1/IF1) as essential for PARK2 recruitment and mitophagy in cultured cells
|
|
GO:1905707
negative regulation of mitochondrial ATP synthesis coupled proton transport
|
IMP
PMID:24005319 Genome-wide RNAi screen identifies ATPase inhibitory factor ... |
ACCEPT |
Summary: IMP annotation from Lefebvre et al. 2013 showing that ATPIF1 blocks ATP synthase from running in reverse (as an ATPase) during uncoupling. The annotation captures the process-level consequence of IF1's ATPase inhibitor activity on ATP synthesis coupled proton transport.
Reason: This annotation correctly captures the core biological process function of IF1. During mitochondrial uncoupling, the F1Fo-ATP synthase can reverse to hydrolyze ATP and pump protons. IF1 inhibits this reversal, effectively negatively regulating the overall ATP synthesis coupled proton transport process. Lefebvre et al. showed "ATPIF1 promotes collapse of delta-psi and activation of the PINK-PARK2 mitophagy pathway by blocking the ATPase activity of the F1-Fo ATP synthase" (PMID:24005319).
Supporting Evidence:
PMID:24005319
During uncoupling, ATPIF1 promotes collapse of ΔΨ and activation of the PINK-PARK2 mitophagy pathway by blocking the ATPase activity of the F 1-Fo ATP synthase
|
|
GO:0005739
mitochondrion
|
IDA
GO_REF:0000052 |
ACCEPT |
Summary: IDA annotation for mitochondrion based on curation of immunofluorescence data (Human Protein Atlas). Direct visualization of IF1 in mitochondria.
Reason: Direct immunofluorescence evidence for mitochondrial localization is consistent with all other evidence. HPA data provides independent confirmation of the core localization.
|
|
GO:0002931
response to ischemia
|
IDA
PMID:35926043 Mitochondrial remodeling and ischemic protection by G protei... |
KEEP AS NON CORE |
Summary: IDA annotation from Wyant et al. 2022 (Science) showing that ATPIF1 is involved in ischemic protection. GPR35 activation led to ATPIF1-dependent ATP synthase dimerization that prevented ATP loss during ischemia. The study demonstrated that "Activated GPR35, in an ATPIF1-dependent and pertussis toxin-sensitive manner, induced ATP synthase dimerization, which prevented ATP loss upon ischemia."
Reason: Response to ischemia is biologically important and experimentally demonstrated, but it represents a physiological context in which IF1's primary ATPase inhibitor function is deployed, rather than the core function itself. IF1's role in ischemic protection is a consequence of its ability to prevent ATP hydrolysis when the proton gradient collapses. This is a key physiological role but secondary to the molecular function.
Supporting Evidence:
PMID:35926043
Activated GPR35, in an ATPIF1-dependent and pertussis toxin-sensitive manner, induced ATP synthase dimerization, which prevented ATP loss upon ischemia
|
|
GO:0010667
negative regulation of cardiac muscle cell apoptotic process
|
IDA
PMID:35926043 Mitochondrial remodeling and ischemic protection by G protei... |
UNDECIDED |
Summary: IDA annotation from Wyant et al. 2022 showing that ATPIF1-dependent ATP synthase dimerization contributes to cardiac protection during ischemia. By preventing ATP depletion, IF1 protects cardiac cells from apoptosis during ischemic stress.
Reason: The accessible evidence supports GPR35/ATPIF1-dependent ATP synthase dimerization and ATP preservation during ischemia, but the cached support does not directly establish negative regulation of cardiac muscle cell apoptosis. Treat this as undecided until direct apoptosis evidence from the paper is available.
Supporting Evidence:
PMID:35926043
Activated GPR35, in an ATPIF1-dependent and pertussis toxin-sensitive manner, induced ATP synthase dimerization, which prevented ATP loss upon ischemia
|
|
GO:0042030
ATPase inhibitor activity
|
TAS
PMID:24005319 Genome-wide RNAi screen identifies ATPase inhibitory factor ... |
ACCEPT |
Summary: TAS annotation for ATPase inhibitor activity based on Lefebvre et al. 2013. The paper describes ATPIF1 as "blocking the ATPase activity of the F1-Fo ATP synthase" during uncoupling.
Reason: ATPase inhibitor activity is the core molecular function. This TAS annotation is consistent with all other evidence for this function. The paper explicitly describes ATPIF1 blocking ATPase activity.
Supporting Evidence:
PMID:24005319
During uncoupling, ATPIF1 promotes collapse of ΔΨ and activation of the PINK-PARK2 mitophagy pathway by blocking the ATPase activity of the F 1-Fo ATP synthase
|
|
GO:0005739
mitochondrion
|
HTP
PMID:34800366 Quantitative high-confidence human mitochondrial proteome an... |
ACCEPT |
Summary: HTP annotation for mitochondrion from Morgenstern et al. 2021, a quantitative high-confidence human mitochondrial proteome study. ATP5IF1 was identified as a high-confidence mitochondrial protein.
Reason: This high-throughput proteomics study provides quantitative evidence for mitochondrial localization. Consistent with all other evidence codes for this localization.
Supporting Evidence:
PMID:34800366
Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context
|
|
GO:1905707
negative regulation of mitochondrial ATP synthesis coupled proton transport
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: ISS annotation transferred from bovine ortholog P01096. The bovine IF1 was the first characterized member of this family and shares high sequence conservation with human IF1. The function is well-conserved.
Reason: This ISS annotation is consistent with the IMP annotation from PMID:24005319 for the same GO term. The bovine ortholog is the best-studied member of this family, and the transfer is appropriate given high sequence conservation and shared function.
|
|
GO:0032991
protein-containing complex
|
ISS
GO_REF:0000024 |
REMOVE |
Summary: ISS annotation indicating IF1 is part of a protein-containing complex, transferred from bovine ortholog P01096. IF1 forms homodimers and associates with the F1Fo-ATP synthase complex.
Reason: While IF1 is indeed part of protein complexes (homodimers and the IF1-ATP synthase complex), "protein-containing complex" is too generic and there is no appropriate same-aspect CC replacement here. The relevant biology is already captured by more specific annotations: mitochondrial localization and the supported MF annotation for mitochondrial proton-transporting ATP synthase complex binding (GO:0140260).
|
|
GO:0042802
identical protein binding
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: ISS annotation for identical protein binding (homodimerization) transferred from bovine ortholog P01096. IF1 forms antiparallel dimers at acidic pH, which is the active inhibitory form, and homotetramers at neutral pH, which is the inactive form.
Reason: Homodimerization is a critical regulatory mechanism for IF1. UniProt states: "Homodimer; represents the active form and is present at a pH value below 6.5. Homotetramer; represents the inactive form and is present at a pH value above 7.0." The antiparallel coiled-coil dimer (residues 74-106) is essential for the inhibitory mechanism. While "identical protein binding" is somewhat generic, it accurately captures the homodimerization property.
Supporting Evidence:
PMID:12110673
IF(1) could be co-isolated with F(1)F(0) when the immunocapture procedure was carried out at pH 6.5 but was absent when the ATP synthase was isolated at pH 8.0
|
|
GO:0140260
mitochondrial proton-transporting ATP synthase complex binding
|
IDA
PMID:12110673 A functionally active human F1F0 ATPase can be purified by i... |
ACCEPT |
Summary: IDA annotation for direct binding to the mitochondrial ATP synthase complex, from Aggeler et al. 2002. The study demonstrated co-immunoprecipitation of IF1 with F1Fo-ATP synthase from human heart mitochondria in a pH-dependent manner.
Reason: This is a core molecular function annotation. Aggeler et al. directly demonstrated that IF1 co-purifies with immunocaptured F1Fo-ATP synthase at pH 6.5 but not at pH 8.0, confirming direct pH-dependent binding. The captured complex could be inhibited >90% by recombinant IF1 and activated >10-fold by pH 8.0 release.
Supporting Evidence:
PMID:12110673
IF(1) could be co-isolated with F(1)F(0) when the immunocapture procedure was carried out at pH 6.5 but was absent when the ATP synthase was isolated at pH 8.0
PMID:12110673
Immunocaptured F(1)F(0) lacking IF(1) could be inhibited by more than 90% by addition of recombinant inhibitor protein
|
|
GO:1905091
positive regulation of type 2 mitophagy
|
IMP
PMID:24005319 Genome-wide RNAi screen identifies ATPase inhibitory factor ... |
KEEP AS NON CORE |
Summary: IMP annotation from Lefebvre et al. 2013 genome-wide RNAi screen. ATPIF1 was identified as essential for PARK2 recruitment to depolarized mitochondria and subsequent mitophagy. ATPIF1 promotes mitochondrial depolarization by blocking reverse ATP synthase activity, which is required for PINK1 stabilization and PARK2 recruitment.
Reason: Mitophagy regulation is an experimentally supported but indirect consequence of IF1's primary ATPase inhibitor activity. IF1 promotes mitophagy by ensuring complete mitochondrial depolarization during uncoupling (by preventing ATP hydrolysis-driven proton pumping), which allows PINK1 accumulation and PARK2 recruitment. This is a downstream biological process rather than a core function.
Supporting Evidence:
PMID:24005319
we identified ATPase inhibitory factor 1 (ATPIF1/IF1) as essential for PARK2 recruitment and mitophagy in cultured cells
PMID:24005319
Restoration of ATPIF1 in Rho0 cells, which lack mtDNA and a functional electron transport chain, lowers ΔΨ and triggers PARK2 recruitment
|
|
GO:0019899
enzyme binding
|
IPI
PMID:21106936 Regenerative protein thymosin beta-4 is a novel regulator of... |
MODIFY |
Summary: IPI annotation for enzyme binding from Freeman et al. 2011. The study focused on thymosin beta-4 (Tbeta4) as a regulator of cell surface ATP synthase in endothelial cells. IF1 was described as having structural similarity to Tbeta4 in silico. The WITH column indicates P06576 (ATP5F1B) and P25705 (ATP5F1A), the beta and alpha subunits of F1-ATP synthase.
Reason: The binding partners (ATP5F1A and ATP5F1B, the alpha and beta subunits of F1-ATP synthase) are correct and represent the core binding target of IF1. However, "enzyme binding" is too generic. The specific binding to the ATP synthase complex is well-characterized and a more specific term exists.
Proposed replacements:
mitochondrial proton-transporting ATP synthase complex binding
Supporting Evidence:
PMID:21106936
we identified common amphiphilic alpha-helical structural similarities between beta-thymosins and the inhibitory factor 1 (IF1), an inhibitor of ATP synthase hydrolysis
|
|
GO:1903747
regulation of protein localization to mitochondrion
|
IMP
PMID:24005319 Genome-wide RNAi screen identifies ATPase inhibitory factor ... |
KEEP AS NON CORE |
Summary: IMP annotation from Lefebvre et al. 2013. ATPIF1 knockdown prevented PARK2 translocation to mitochondria. By promoting mitochondrial depolarization (blocking reverse ATP synthase), ATPIF1 enables the PINK1-dependent recruitment of PARK2 to damaged mitochondria.
Reason: This annotation captures a specific aspect of the mitophagy pathway: IF1-dependent regulation of PARK2 localization to mitochondria. While experimentally supported by the RNAi screen, this is an indirect downstream effect. IF1 does not directly regulate protein localization machinery; it enables PARK2 recruitment by ensuring mitochondrial depolarization through its ATPase inhibitor activity.
Supporting Evidence:
PMID:24005319
we identified ATPase inhibitory factor 1 (ATPIF1/IF1) as essential for PARK2 recruitment and mitophagy in cultured cells
|
|
GO:0051882
mitochondrial depolarization
|
IMP
PMID:24005319 Genome-wide RNAi screen identifies ATPase inhibitory factor ... |
ACCEPT |
Summary: IMP annotation from Lefebvre et al. 2013. ATPIF1 promotes collapse of the mitochondrial membrane potential during uncoupling by blocking the reverse ATPase activity that would otherwise maintain membrane potential by pumping protons.
Reason: Mitochondrial depolarization is a direct and proximal consequence of IF1's core ATPase inhibitor activity. When the electron transport chain fails or is uncoupled, ATP synthase reverses to hydrolyze ATP and pump protons, partially maintaining membrane potential. IF1 blocks this reversal, allowing complete depolarization. This is a direct functional outcome and closely tied to the core mechanism. The paper states: "During uncoupling, ATPIF1 promotes collapse of delta-psi... by blocking the ATPase activity of the F1-Fo ATP synthase."
Supporting Evidence:
PMID:24005319
During uncoupling, ATPIF1 promotes collapse of ΔΨ and activation of the PINK-PARK2 mitophagy pathway by blocking the ATPase activity of the F 1-Fo ATP synthase
PMID:24005319
Restoration of ATPIF1 in Rho0 cells, which lack mtDNA and a functional electron transport chain, lowers ΔΨ and triggers PARK2 recruitment
|
|
GO:0005739
mitochondrion
|
HDA
PMID:20833797 Phosphoproteome analysis of functional mitochondria isolated... |
ACCEPT |
Summary: HDA annotation for mitochondrial localization from Zhao et al. 2011, a phosphoproteomics study of functional mitochondria isolated from human muscle. IF1 was detected in the mitochondrial phosphoproteome.
Reason: This high-throughput direct assay evidence for mitochondrial localization is consistent with all other evidence. The protein was identified in isolated mitochondria from human skeletal muscle.
Supporting Evidence:
PMID:20833797
Phosphoproteome analysis of functional mitochondria isolated from resting human muscle reveals extensive phosphorylation of inner membrane protein complexes and enzymes
|
|
GO:0042030
ATPase inhibitor activity
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: ISS annotation for ATPase inhibitor activity transferred from bovine ortholog P01096. The bovine IF1 is the best-characterized member of this protein family.
Reason: This is the core molecular function, and the transfer from the bovine ortholog is appropriate given high sequence conservation and identical function. Consistent with IDA and IBA annotations for the same term.
|
|
GO:0005739
mitochondrion
|
IDA
PMID:12110673 A functionally active human F1F0 ATPase can be purified by i... |
ACCEPT |
Summary: IDA annotation for mitochondrial localization from Aggeler et al. 2002. IF1 was identified as a subunit of the immunocaptured F1Fo-ATP synthase complex from human heart mitochondria and fibroblasts.
Reason: Direct experimental evidence from immunocapture of mitochondrial ATP synthase complex. IF1 was detected with specific antibody and co-purified with the complex from mitochondria.
Supporting Evidence:
PMID:12110673
The immunoprecipitated F(1)F(0) contained a full complement of subunits that were identified with specific antibodies against five of the subunits (alpha, beta, OSCP, d, and IF(1))
|
|
GO:0042030
ATPase inhibitor activity
|
IDA
PMID:12110673 A functionally active human F1F0 ATPase can be purified by i... |
ACCEPT |
Summary: IDA annotation for ATPase inhibitor activity from Aggeler et al. 2002. The study directly demonstrated that recombinant IF1 inhibited ATP hydrolysis by immunocaptured F1Fo-ATP synthase by >90%, and that removal of IF1 at pH 8.0 activated the enzyme >10-fold.
Reason: This is direct experimental evidence for the core molecular function. The quantitative inhibition data (>90% inhibition by recombinant IF1, >10-fold activation upon IF1 release) provides strong support for ATPase inhibitor activity.
Supporting Evidence:
PMID:12110673
Immunocaptured F(1)F(0) lacking IF(1) could be inhibited by more than 90% by addition of recombinant inhibitor protein, and conversely, F(1)F(0) containing IF(1) could be activated more than 10-fold by brief exposure to pH 8.0, inducing the release of inhibitor protein
|
|
GO:0001525
angiogenesis
|
TAS
PMID:15528193 An Inhibitor of the F1 subunit of ATP synthase (IF1) modulat... |
KEEP AS NON CORE |
Summary: TAS annotation for angiogenesis from Burwick et al. 2005. The study explored IF1's effect on cell surface ATP synthase in endothelial cells and its relationship with angiostatin-mediated anti-angiogenesis. IF1 was proposed to have a "protective role for EC in the tumor microenvironment" that could be overridden by angiostatin.
Reason: The paper studied IF1 in the context of cell surface ATP synthase and angiostatin, concluding that IF1 is NOT an angiostatin mimetic and only "slightly inhibited cell proliferation compared with angiostatin." The connection to angiogenesis is indirect through the cell surface ATP synthase-angiostatin axis. This is a peripheral, non-core function related to the unusual cell surface localization of IF1/ATP synthase, not the primary mitochondrial function.
Supporting Evidence:
PMID:15528193
We propose that IF1 is not an angiostatin mimetic, but it can serve a protective role for EC in the tumor microenvironment
PMID:15528193
IF1 did not inhibit EC differentiation to form tubes and only slightly inhibited cell proliferation compared with angiostatin
|
|
GO:0001937
negative regulation of endothelial cell proliferation
|
IDA
PMID:15528193 An Inhibitor of the F1 subunit of ATP synthase (IF1) modulat... |
MARK AS OVER ANNOTATED |
Summary: IDA annotation from Burwick et al. 2005 showing that exogenous IF1 "only slightly inhibited cell proliferation compared with angiostatin." The paper explicitly states the effect was minor.
Reason: The paper itself states IF1 "only slightly inhibited cell proliferation compared with angiostatin." This is a marginal effect observed with exogenous IF1 on cell surface ATP synthase, not the protein's primary function. The anti-proliferative effect was weak and the authors concluded IF1 is "not an angiostatin mimetic." This represents an over-annotation of a minor experimental observation.
Supporting Evidence:
PMID:15528193
IF1 did not inhibit EC differentiation to form tubes and only slightly inhibited cell proliferation compared with angiostatin
|
|
GO:0005516
calmodulin binding
|
ISS
GO_REF:0000024 |
UNDECIDED |
Summary: ISS annotation for calmodulin binding transferred from bovine ortholog P01096. Calmodulin has been reported to interact with IF1 in bovine systems, potentially regulating its activity or oligomeric state.
Reason: The calmodulin binding annotation is transferred from the bovine ortholog. While there is some evidence for calmodulin-IF1 interaction in bovine systems, the physiological significance and whether this applies to human IF1 is not well-established in the publications available for review. The core regulatory mechanisms of IF1 (pH-dependent oligomerization and Ser39 phosphorylation) are well-documented, but calmodulin regulation is less certain. Without access to the primary bovine literature supporting this claim, this should remain undecided.
|
|
GO:0005739
mitochondrion
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: ISS annotation for mitochondrion transferred from bovine ortholog P01096. Consistent with all other evidence for mitochondrial localization.
Reason: Mitochondrial localization is well-established for IF1 across species. This ISS transfer is consistent with IDA, IBA, IEA, HTP, HDA, and TAS evidence for the same localization.
|
|
GO:0009986
cell surface
|
IDA
PMID:15528193 An Inhibitor of the F1 subunit of ATP synthase (IF1) modulat... |
KEEP AS NON CORE |
Summary: IDA annotation for cell surface localization from Burwick et al. 2005. The study showed IF1 interacting with cell surface F1-ATP synthase on endothelial cells. The paper demonstrated IF1 binding to purified F1 and its effects on cell surface ATP hydrolysis.
Reason: Cell surface localization of IF1 (and ATP synthase) has been reported on endothelial cells. While the primary localization of IF1 is mitochondrial, the cell surface localization appears to be a genuine but secondary location. The biological significance of cell surface IF1 is debated, and it may represent ectopic localization in certain cell types rather than a core function.
Supporting Evidence:
PMID:15528193
IF1 protein bound to purified F(1) ATP synthase and inhibited F(1)-dependent ATP hydrolysis consistent with its reported activity in studies of mitochondria
|
|
GO:0042030
ATPase inhibitor activity
|
IDA
PMID:15528193 An Inhibitor of the F1 subunit of ATP synthase (IF1) modulat... |
ACCEPT |
Summary: IDA annotation for ATPase inhibitor activity from Burwick et al. 2005. The study confirmed IF1 inhibited F1-dependent ATP hydrolysis both with purified enzyme and on the cell surface.
Reason: The paper directly demonstrates ATPase inhibitor activity, consistent with the core function. IF1 inhibited ATP hydrolysis but notably "did not inhibit ATP synthesis" on the cell surface, confirming its specific ATPase (hydrolysis) inhibitor activity.
Supporting Evidence:
PMID:15528193
IF1 protein bound to purified F(1) ATP synthase and inhibited F(1)-dependent ATP hydrolysis consistent with its reported activity in studies of mitochondria
PMID:15528193
IF1 inhibited ATP hydrolysis but not ATP synthesis, in contrast to angiostatin, which inhibited both
|
|
GO:0043532
angiostatin binding
|
IDA
PMID:15528193 An Inhibitor of the F1 subunit of ATP synthase (IF1) modulat... |
UNDECIDED |
Summary: IDA annotation for angiostatin binding from Burwick et al. 2005. The study showed that "angiostatin blocks IF1 binding to ATP synthase and abolishes its ability to conserve ATP," suggesting overlapping binding sites. However, this demonstrates competition for ATP synthase binding, not necessarily direct IF1-angiostatin binding.
Reason: The paper demonstrates that angiostatin and IF1 compete for binding to ATP synthase, which implies overlapping binding sites on the enzyme rather than direct IF1-angiostatin binding. The statement "there is a relationship between the binding sites of IF1 and angiostatin on ATP synthase" supports competition, not direct binding. Without access to the full text to determine whether direct binding was actually demonstrated (rather than competition), this remains unclear.
Supporting Evidence:
PMID:15528193
angiostatin blocks IF1 binding to ATP synthase and abolishes its ability to conserve ATP
PMID:15528193
These data suggest that there is a relationship between the binding sites of IF1 and angiostatin on ATP synthase
|
|
GO:0051117
ATPase binding
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: ISS annotation for ATPase binding transferred from bovine ortholog P01096. Consistent with the IBA and IDA annotations for this term.
Reason: ATPase binding is a core function, and this ISS transfer from the bovine ortholog is well-supported by multiple experimental evidence types for the same term.
|
|
GO:0051117
ATPase binding
|
IDA
PMID:15528193 An Inhibitor of the F1 subunit of ATP synthase (IF1) modulat... |
ACCEPT |
Summary: IDA annotation for ATPase binding from Burwick et al. 2005. The study demonstrated direct binding of IF1 to purified F1 ATP synthase.
Reason: The paper directly demonstrates IF1 binding to F1-ATP synthase. This is a core function well-supported by multiple lines of evidence.
Supporting Evidence:
PMID:15528193
IF1 protein bound to purified F(1) ATP synthase and inhibited F(1)-dependent ATP hydrolysis
|
|
GO:0051346
negative regulation of hydrolase activity
|
IDA
PMID:15528193 An Inhibitor of the F1 subunit of ATP synthase (IF1) modulat... |
ACCEPT |
Summary: IDA annotation for negative regulation of hydrolase activity from Burwick et al. 2005. IF1 inhibited ATP hydrolysis activity of the F1-ATP synthase both in purified form and on the cell surface.
Reason: This annotation accurately captures the core process-level function of IF1 at a somewhat general level. IF1 negatively regulates the ATP hydrolase activity of F1Fo-ATP synthase. While GO:1905707 (negative regulation of mitochondrial ATP synthesis coupled proton transport) is more specific, this term is also accurate as a broader description of the mechanism.
Supporting Evidence:
PMID:15528193
IF1 inhibited ATP hydrolysis but not ATP synthesis
|
|
GO:0004857
enzyme inhibitor activity
|
TAS
PMID:10664857 Nucleotide sequence of cDNA coding the mitochondrial precurs... |
MODIFY |
Summary: TAS annotation for enzyme inhibitor activity from Ichikawa et al. 1999, the paper reporting the human cDNA sequence. The paper describes the protein as "the ATPase inhibitor" based on sequence homology to the bovine inhibitor protein.
Reason: While IF1 is indeed an enzyme inhibitor, "enzyme inhibitor activity" (GO:0004857) is too general. The more specific term "ATPase inhibitor activity" (GO:0042030) is already annotated and better captures the specific function. This general term should be replaced with the more specific one.
Proposed replacements:
ATPase inhibitor activity
Supporting Evidence:
PMID:10664857
cDNA coding the human homolog of the inhibitor protein was isolated and sequenced
|
|
GO:0005739
mitochondrion
|
TAS
PMID:10664857 Nucleotide sequence of cDNA coding the mitochondrial precurs... |
ACCEPT |
Summary: TAS annotation for mitochondrion from Ichikawa et al. 1999. The paper describes the protein as "the mitochondrial precursor protein of the ATPase inhibitor from humans."
Reason: Mitochondrial localization is stated in the paper title and is consistent with all other evidence. The paper describes the mitochondrial transit peptide and identifies the protein as a mitochondrial ATPase inhibitor.
Supporting Evidence:
PMID:10664857
cDNA coding the mitochondrial precursor protein of the ATPase inhibitor from humans
|
|
GO:0006091
generation of precursor metabolites and energy
|
TAS
PMID:10664857 Nucleotide sequence of cDNA coding the mitochondrial precurs... |
MODIFY |
Summary: TAS annotation for generation of precursor metabolites and energy from Ichikawa et al. 1999. This is a very broad biological process term covering all of energy metabolism.
Reason: This term is too broad. IF1 does not generally participate in "generation of precursor metabolites and energy" -- it specifically inhibits ATP hydrolysis by the F1Fo-ATP synthase. The more specific term GO:1905707 (negative regulation of mitochondrial ATP synthesis coupled proton transport) better captures the actual process. Alternatively, GO:1903578 (regulation of ATP metabolic process) would be more appropriate.
Proposed replacements:
negative regulation of mitochondrial ATP synthesis coupled proton transport
|
|
GO:0005759
mitochondrial matrix
|
IDA
PMID:12110673 A functionally active human F1F0 ATPase can be purified by i... |
NEW |
Summary: The mature IF1 protein functions in the mitochondrial matrix, where it binds the F1 catalytic domain on the matrix-facing side of the inner membrane. While "mitochondrion" is annotated, the more specific sub-compartment (mitochondrial matrix) is not explicitly annotated. UniProt states: "Mitochondrion" as subcellular location, and the deep research notes that IF1 acts "on the matrix side of the F1 catalytic domain." Cryo-EM structures (PDB: 8H9E, 8H9L, 8H9S, 8H9U, 8KI3) place IF1 bound to the F1 domain which projects into the matrix.
Reason: The mitochondrial matrix is the specific sub-compartment where IF1 is active. The F1 domain that IF1 binds faces the matrix. This more specific CC annotation is supported by structural data and functional characterization. While "mitochondrion" is annotated, the matrix localization should be explicitly noted.
Supporting Evidence:
PMID:12110673
IF(1) could be co-isolated with F(1)F(0) when the immunocapture procedure was carried out at pH 6.5
|
The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
Plan and approach
- Verified identity and scope before research. Target gene/protein matches UniProt Q9UII2: human ATP5IF1 (aliases: IF1, ATPIF1, ATPI) encoding the mitochondrial ATPase inhibitor family protein; literature describes membership in ATPase inhibitor family and the characteristic mitochondrial ATPase_inhibitor_mt/IATP domain organization. Reviewed authoritative recent sources (2022–2024) and primary 2023–2024 studies for mechanism, regulation, structure, localization, and disease roles. Where the 2023–2024 primary data were not retrievable in our evidence set, we provide a partial summary and note the gap.
Executive summary
- Identity and definition: ATP5IF1 (IF1) is a small, nuclear-encoded, mitochondrial protein that inhibits the F1Fo-ATP synthase (complex V). It is imported as a precursor and, in its mature form (≈81 aa), binds the F1 catalytic region to block rotary catalysis; IF1 belongs to the ATPase inhibitor family and is conserved in mammals. Tissue expression is variable and subject to post-transcriptional regulation (human > mouse in several tissues) (gore2022themultifacetedatpase pages 1-2, gatto2022thef1foatpaseinhibitor pages 1-2, solaini2021thef1foatpaseinhibitor pages 1-5).
- Core mechanism: IF1 is a reversible, pH-sensitive inhibitor that primarily prevents wasteful ATP hydrolysis when Δψm collapses, but can also inhibit ATP synthesis in some contexts. Acidic matrix pH promotes active dimers; near-neutral pH favors inactive tetramers. Phosphorylation at Ser39 by a mitochondrial PKA-like activity renders IF1 inactive (cannot bind ATP synthase), whereas dephosphorylation restores inhibition (gatto2022thef1foatpaseinhibitor pages 1-2, gore2022themultifacetedatpase pages 2-5, cuezva2024theatpaseinhibitory pages 12-14, solaini2021thef1foatpaseinhibitor pages 5-8).
- Interfaces and structural insights: IF1 binds the F1 catalytic site formed by α/β subunits and contacts γ; in respiring human cancer cells, IF1 also binds the OSCP subunit, and this IF1–OSCP interaction protects from permeability transition and apoptosis. NMR mapping localizes the OSCP-binding interface to IF1 E29–R39 and OSCP helix/shoulder residues A53–I64; IF1 dimers are detected in complexes (solaini2021thef1foatpaseinhibitor pages 5-8, galber2023themitochondrialinhibitor pages 2-4).
- Physiological and disease roles (recent): In cancer, IF1 and the ATP synthase/IF1 axis are linked to glycolytic reprogramming, oligomerization of ATP synthase and cristae remodeling, and apoptosis resistance. 2023–2024 studies report OSCP binding that protects from apoptosis and peptide disruptors that displace IF1 to sensitize cancer mitochondria (dominguezzorita2023themitochondrialatp pages 4-6, cuezva2024theatpaseinhibitory pages 12-14, galber2023themitochondrialinhibitor pages 2-4, grandi2024peptidestargetingthe pages 15-16).
- Interventions and applications (recent): (i) Mitochondria-targeted peptides can disrupt the IF1–OSCP interaction and modulate mPT without impairing respiration, suggesting a druggable site (2024). (ii) Reviews emphasize S39 phosphorylation as a regulatory node for metabolic control and potential biomarker utility of IF1 in oncology and cardiometabolic settings (2024) (grandi2024peptidestargetingthe pages 15-16, cuezva2024theatpaseinhibitory pages 12-14, dominguezzorita2023themitochondrialatp pages 4-6).
1) Key concepts and definitions with current understanding
- Gene/protein identity and family: ATP5IF1 encodes ATPase inhibitory factor 1 (IF1), an endogenous regulator of mitochondrial F1Fo-ATP synthase (complex V). IF1 is a small, basic protein imported into the matrix; homologs exist across eukaryotes. It is grouped within the ATPase inhibitor family and exerts reversible, non-competitive inhibition of the F1 catalytic rotary mechanism (gore2022themultifacetedatpase pages 1-2, gatto2022thef1foatpaseinhibitor pages 1-2, solaini2021thef1foatpaseinhibitor pages 1-5).
- Fundamental role: IF1 prevents ATP wastage by inhibiting ATP hydrolysis during conditions of low proton motive force (e.g., ischemia/hypoxia), and, depending on cell type and regulation, can also inhibit forward ATP synthesis, thereby promoting glycolytic reprogramming and mitohormetic signaling (gore2022themultifacetedatpase pages 1-2, dominguezzorita2023themitochondrialatp pages 4-6, solaini2021thef1foatpaseinhibitor pages 1-5).
2) Mechanism of action and regulation
- pH-dependent oligomerization/activation: Matrix acidification (≈pH 6.5–6.7) drives formation of the active antiparallel IF1 dimer that binds two F1 catalytic sites; neutral/alkaline pH promotes higher-order oligomers (e.g., tetramers) that mask the N-terminal inhibitory elements, reducing binding. Histidine protonation (e.g., H49) contributes to this pH switch (Aug 2022; Frontiers in Physiology) (gatto2022thef1foatpaseinhibitor pages 1-2). Reviews concur that oligomer state tightly controls inhibitory competence (Aug 2022; Antioxidants & Redox Signaling) (gore2022themultifacetedatpase pages 1-2).
- Catalytic block and binding within F1: Structural/biochemical analyses place the IF1 N-terminal inhibitory helix in a cleft of the α/β catalytic interface, contacting γ and obstructing rotary catalysis during ATP hydrolysis. IF1 can engage the empty βE site and, after two ATP hydrolysis steps (two 120° rotations), fully insert to lock the motor (Apr 2021; Biochem. Soc. Trans.) (solaini2021thef1foatpaseinhibitor pages 5-8).
- Post-translational regulation (Ser39): Phosphorylation of IF1 Ser39 by a mitochondrial PKA-like activity prevents IF1–ATP synthase binding and blocks inhibitory action. Dephosphorylated IF1 is active and associates with the enzyme; several cancers show dephosphorylated (active) IF1. A 2024 review strongly emphasizes S39 phosphorylation as an in vivo regulatory switch linked to the Warburg phenotype (Feb 2024; Cancers) and prior in vivo reports of mitochondrial cAMP–PKA activity (cuezva2024theatpaseinhibitory pages 12-14, gore2022themultifacetedatpase pages 2-5).
- Additional interface (OSCP) and apoptosis control: In respiring mitochondria from cancer cells, IF1 binds the ATP synthase OSCP subunit (N-terminus), distinct from classical F1 binding. NMR mapping localizes the interface (IF1 E29–R39; OSCP A53–I64), and genetic loss of IF1 sensitizes to permeability transition pore opening and apoptosis without altering oligomycin-sensitive respiration, indicating a structural, protective role of the IF1–OSCP contact under OXPHOS conditions (Jan 2023; Cell Death & Disease) (galber2023themitochondrialinhibitor pages 2-4).
3) Structural/assembly insights (cryo-EM and organization)
- ATP synthase organization and IF1-bound assemblies: Modern cryo-EM has revealed mammalian ATP synthase dimers/oligomers that bend cristae membranes. Reviews summarizing these structures highlight IF1 bound to ATP synthase within higher-order assemblies and discuss how IF1-associated oligomerization could stabilize cristae architecture and modulate activity states (Apr 2021; Biochem. Soc. Trans.; Aug 2022; Front. Physiol.) (solaini2021thef1foatpaseinhibitor pages 5-8, gatto2022thef1foatpaseinhibitor pages 1-2).
- Spatial distribution concept: Functional studies indicate IF1 promotes oligomerization and may segregate inactive (“sluggish”) ATP synthase pools, often localized to cristae microdomains, thereby contributing to membrane potential heterogeneity; these phenomena are discussed in recent reviews on the ATP synthase/IF1 axis in cancer (Jul 2023; Cancers) (dominguezzorita2023themitochondrialatp pages 4-6).
4) Subcellular localization and tissue expression
- Localization: IF1 is mitochondrial, acting on the matrix side of the F1 catalytic domain and at the peripheral stalk OSCP interface under certain conditions in human cancer cells (galber2023themitochondrialinhibitor pages 2-4, solaini2021thef1foatpaseinhibitor pages 5-8).
- Tissue expression: Reviews document tissue-restricted and species-divergent expression; human heart and brain can exhibit relatively high IF1 protein content compared to liver/kidney, while mice often show lower IF1 in some tissues. Expression is subject to post-transcriptional and post-translational regulation, leading to variable IF1:ATP synthase ratios between tissues and species (Aug 2022; Front. Physiol.; Aug 2022; Antioxid. Redox Signal.) (gatto2022thef1foatpaseinhibitor pages 1-2, gore2022themultifacetedatpase pages 1-2).
5) Recent developments and latest research (prioritizing 2023–2024)
- Cancer cell survival via OSCP binding (2023): Demonstration that IF1 binds OSCP in respiring mitochondria and protects cancer cells from PTP-dependent apoptosis; IF1 loss reduces tumorigenicity in soft agar and zebrafish xenografts. Mapping of the IF1–OSCP interface supports a defined druggable surface (Jan 2023; Cell Death & Disease) (galber2023themitochondrialinhibitor pages 2-4).
- Peptide disruption of IF1–OSCP (2024): Mitochondria-targeted peptides were engineered to displace IF1 from OSCP; one peptide bound the OSCP N-terminus overlapping the IF1 region, modulating permeability transition in HeLa cells without impairing respiration—proof-of-concept for therapeutics targeting the IF1–OSCP axis (Apr 2024; Int. J. Mol. Sci.) (grandi2024peptidestargetingthe pages 15-16).
- IF1 regulation and Warburg effect (2024): A contemporaneous review consolidates evidence that IF1 contributes to the Warburg effect by inhibiting a fraction of ATP synthase under normoxia and that S39 phosphorylation by mitochondrial PKA inactivates IF1, providing a regulatory logic for toggling ATP synthase activity and glycolytic reprogramming (Feb 2024; Cancers) (cuezva2024theatpaseinhibitory pages 12-14).
- State-of-the-field oncology review (2023): The ATP synthase/IF1 axis is highlighted as a context-dependent driver of tumor progression and as a target for metabolic therapy; emphasis is placed on cell-type specificity of IF1’s effects on metastasis and apoptosis (Jul 2023; Cancers) (dominguezzorita2023themitochondrialatp pages 4-6).
6) Current applications and real-world implementations
- Therapeutic targeting of the IF1–OSCP interface: 2024 peptide studies show feasibility of selectively displacing IF1 from ATP synthase to sensitize cancer mitochondria to mPT without broadly inhibiting respiration, suggesting a novel class of mitochondria-targeted therapeutics (grandi2024peptidestargetingthe pages 15-16).
- Biomarker potential: Reviews note the use of IF1 levels as a biomarker in cardiovascular disease and the broader proposition of IF1 as a cancer biomarker, though clinical implementation requires further validation (Aug 2022; Antioxidants & Redox Signaling; Jul 2023; Cancers) (gore2022themultifacetedatpase pages 1-2, dominguezzorita2023themitochondrialatp pages 4-6).
7) Expert opinions and analysis from authoritative sources
- Consensus and controversy: High-quality reviews converge that IF1 is a central regulator of ATP synthase with strong pH- and phosphorylation-dependent control. There is an ongoing, evidence-based debate regarding the extent to which IF1 inhibits ATP synthesis under normoxia across cell types; recent reviews articulate the case for in vivo inhibition of a subset of ATP synthase molecules contributing to glycolytic reprogramming, balanced against studies emphasizing a primary role only during reverse (hydrolytic) operation (Apr 2021; Biochem. Soc. Trans.; Aug 2022; Antioxid. Redox Signal.; Jul 2023 and Feb 2024; Cancers) (solaini2021thef1foatpaseinhibitor pages 1-5, gore2022themultifacetedatpase pages 1-2, dominguezzorita2023themitochondrialatp pages 4-6, cuezva2024theatpaseinhibitory pages 12-14).
8) Relevant statistics and quantitative data from recent studies
- OSCP binding and tumor biology (2023): In HeLa cells, IF1 deletion did not change oligomycin-sensitive respiration but increased sensitivity to PTP opening; IF1 supported anchorage-independent growth and tumor formation in zebrafish xenografts (directional outcomes reported; precise effect sizes not provided in our excerpts) (Jan 2023; Cell Death & Disease) (galber2023themitochondrialinhibitor pages 2-4).
- Peptide displacement (2024): Peptides that disrupt IF1–OSCP reduced mitochondrial permeability transition in situ in HeLa cells (qualitative and directional effects reported; detailed numeric effect sizes not captured in excerpt) (Apr 2024; Int. J. Mol. Sci.) (grandi2024peptidestargetingthe pages 15-16).
- Note on limitations: Additional 2023–2024 quantitative findings (e.g., in immune cells, AML chemoresistance, heart failure, brown adipose thermogenesis, β-cell function) were referenced in planning but were not retrievable within the present evidence set; therefore, they are not reported here to maintain citation fidelity (pqac-IDs unavailable for those specific claims).
Key source summary table
| Year | Study type | Main finding | Biological context | Mechanism / Interface | Applications / implications | URL / DOI | Citation ID |
|---|---|---|---|---|---|---|---|
| 2023 | Review | Describes the ATP synthase/IF1 axis in cancer; IF1 can promote metabolic reprogramming to glycolysis and exerts cell-type-specific pro- or anti-metastatic effects. | Human cancer cells and tumour studies | IF1-mediated inhibition of ATP synthase, oligomerization, pH-dependence; discusses Ser39 phosphorylation regulation. | Highlights ATP synthase/IF1 as a therapeutic target and biomarker candidate in cancer. | https://doi.org/10.3390/cancers15153775 | (dominguezzorita2023themitochondrialatp pages 4-6) |
| 2024 | Review | Argues IF1 contributes to the Warburg effect and is inactivated by Ser39 phosphorylation by a mitochondrial PKA-like activity, preventing IF1 binding to ATP synthase. | Cancer / mammalian studies | Ser39 (S39) phosphorylation regulation; IF1 inhibition of ATP synthase linked to glycolytic switch. | Implicates S39 phosphorylation as a regulatory node with therapeutic/biomarker relevance. | https://doi.org/10.3390/cancers16051014 | (cuezva2024theatpaseinhibitory pages 12-14) |
| 2023 | Primary (cell + structural NMR) | Shows IF1 binds the OSCP N‑terminal domain (mapped to IF1 E29–R39) and that IF1–OSCP interaction protects cancer cells from PTP-dependent apoptosis. | HeLa cells; cancer models (xenograft assays) | IF1–OSCP interface (OSCP helix/shoulder residues A53–I64); IF1 dimer observed in complexes. | Suggests OSCP–IF1 interface as a druggable target to sensitize cancer cells to apoptosis. | https://doi.org/10.1038/s41419-023-05572-y | (galber2023themitochondrialinhibitor pages 2-4) |
| 2024 | Primary (cellular / peptide intervention) | Mitochondria-targeted peptides can displace IF1 from ATP synthase (OSCP region) and modulate mitochondrial permeability transition in HeLa cells. | HeLa cells (cancer) | Peptides disrupt IF1–OSCP interaction; NMR supports binding to OSCP N‑terminus overlapping IF1 site. | Demonstrates peptide-based strategy to counteract IF1 anti-apoptotic function — potential anti-cancer approach. | https://doi.org/10.3390/ijms25094655 | (grandi2024peptidestargetingthe pages 15-16) |
| 2022 | Review | Comprehensive review: IF1 regulates OXPHOS, mitochondrial quality control and can inhibit ATP synthesis in some contexts; detectable extracellularly and proposed as cardiovascular biomarker. | Broad (human tissues, disease contexts) | Summarizes oligomerization/pH regulation, post-translational marks (including phosphorylation), and effects on respiration/ROS. | Frames IF1 as multifaceted regulator and encourages organ-level studies for therapeutic exploitation. | https://doi.org/10.1089/ars.2021.0137 | (gore2022themultifacetedatpase pages 1-2) |
| 2022 | Review | IF1 is a reversible, pH‑sensitive inhibitor of ATP hydrolysis (optimal inhibitory pH ~6.5–6.7); H49 implicated in pH‑dependent oligomerization (dimer↔tetramer). | Pathophysiology across tissues (heart, liver, brain) | pH sensor (H49), dimer/tetramer equilibrium controls exposure of N‑terminal inhibitory region; mitochondrial matrix localization. | Implications for ischemia protection and emerging roles in cancer and neurodegeneration. | https://doi.org/10.3389/fphys.2022.917203 | (gatto2022thef1foatpaseinhibitor pages 1-2) |
| 2021 | Review | IF1 overexpression in many cancers linked to survival under anoxia; debate remains whether IF1 inhibits ATP synthesis under normoxia. | Cancer cells / metabolic studies | Emphasizes pH‑dependent oligomerization and inhibitory mechanism during reverse (hydrolytic) mode; discusses structural evidence. | Highlights IF1 as a potential oncogenic driver and as a contentious therapeutic target. | https://doi.org/10.1042/bst20200742 | (solaini2021thef1foatpaseinhibitor pages 1-5) |
| 2021 | Primary (mouse neuronal study) | IF1 dose modulates mitochondrial ROS generation and mitohormetic signaling; IF1 overexpression enhances synaptic transmission and learning, while ablation impairs memory. | Mouse neurons / in vivo cognition models | IF1 level controls active/inactive ATP synthase fraction, altering mtROS signaling and downstream transcriptional programs. | Links IF1 to neuronal function and cognition; suggests mtROS-mediated signaling as mechanistic basis. | https://doi.org/10.17863/cam.70424 | (esparzamolto2021generationofmitochondrial pages 30-31) |
Table: Concise summary table of recent (mainly 2023–2024) authoritative sources on human ATP5IF1/IF1, listing study type, main findings, biological context, mechanistic interfaces, translational implications, and DOIs for follow-up.
Verification of identity and domain/family alignment (mandatory checks)
- Symbol and accession: The literature reviewed consistently refers to human IF1 encoded by ATP5IF1 (aliases ATPIF1, IF1), matching UniProt Q9UII2 and Homo sapiens. All mechanistic/structural discussions pertain to the ATPase inhibitor family protein that binds the mitochondrial F1Fo-ATP synthase, aligning with the provided domains (ATPase_inhibitor_mt/IATP) (gore2022themultifacetedatpase pages 1-2, gatto2022thef1foatpaseinhibitor pages 1-2, solaini2021thef1foatpaseinhibitor pages 1-5).
- Ambiguity check: No conflicting gene symbol usage for non-human or unrelated proteins was identified in the cited sources; all primary 2023–2024 studies explicitly study human IF1 or its direct mammalian homologs (galber2023themitochondrialinhibitor pages 2-4, grandi2024peptidestargetingthe pages 15-16, dominguezzorita2023themitochondrialatp pages 4-6, cuezva2024theatpaseinhibitory pages 12-14).
Annotated references with URLs and publication dates
- Cuezva JM, Domínguez-Zorita S. The ATPase Inhibitory Factor 1 (IF1) contributes to the Warburg effect and is regulated by its phosphorylation in S39 by a Protein Kinase A-like activity. Cancers. Feb 2024. URL: https://doi.org/10.3390/cancers16051014 (cuezva2024theatpaseinhibitory pages 12-14).
- Domínguez-Zorita S, Cuezva J. The Mitochondrial ATP Synthase/IF1 Axis in Cancer Progression: Targets for Therapeutic Intervention. Cancers. Jul 2023. URL: https://doi.org/10.3390/cancers15153775 (dominguezzorita2023themitochondrialatp pages 4-6).
- Galber C, et al. The mitochondrial inhibitor IF1 binds to the ATP synthase OSCP subunit and protects cancer cells from apoptosis. Cell Death & Disease. Jan 2023. URL: https://doi.org/10.1038/s41419-023-05572-y (galber2023themitochondrialinhibitor pages 2-4).
- Grandi M, et al. Peptides Targeting the IF1–ATP Synthase Complex Modulate the Permeability Transition Pore in Cancer HeLa Cells. Int J Mol Sci. Apr 2024. URL: https://doi.org/10.3390/ijms25094655 (grandi2024peptidestargetingthe pages 15-16).
- Gore E, et al. The Multifaceted ATPase Inhibitory Factor 1 (IF1) in Energy Metabolism Reprogramming and Mitochondrial Dysfunction. Antioxidants & Redox Signaling. Aug 2022. URL: https://doi.org/10.1089/ars.2021.0137 (gore2022themultifacetedatpase pages 1-2).
- Gatto C, et al. The F1Fo-ATPase inhibitor protein IF1 in pathophysiology. Frontiers in Physiology. Aug 2022. URL: https://doi.org/10.3389/fphys.2022.917203 (gatto2022thef1foatpaseinhibitor pages 1-2).
- Solaini G, et al. The F1Fo-ATPase inhibitor, IF1, is a critical regulator of energy metabolism in cancer cells. Biochem Soc Trans. Apr 2021. URL: https://doi.org/10.1042/bst20200742 (solaini2021thef1foatpaseinhibitor pages 1-5).
- Esparza-Moltó PB, et al. Generation of mitochondrial ROS is controlled by IF1 and regulates cognition. May 2021. URL: https://doi.org/10.17863/cam.70424 (esparzamolto2021generationofmitochondrial pages 30-31).
Conclusions and open questions (anchored in current evidence)
- ATP5IF1 (IF1) is a validated mitochondrial ATP synthase inhibitor in humans, with strong, recent support for nuanced in vivo regulation via pH-dependent oligomerization and Ser39 phosphorylation. In cancer models, IF1 also binds OSCP during OXPHOS to suppress permeability transition and apoptosis, offering a druggable interface now probed by mitochondria-targeted peptides. Unresolved points include the breadth of IF1-mediated inhibition of ATP synthesis under normoxia across tissues and the clinical utility of modulating S39 phosphorylation or OSCP interaction in patients. Targeted, mechanism-informed trials will be needed to translate these insights (solaini2021thef1foatpaseinhibitor pages 5-8, cuezva2024theatpaseinhibitory pages 12-14, galber2023themitochondrialinhibitor pages 2-4, grandi2024peptidestargetingthe pages 15-16, dominguezzorita2023themitochondrialatp pages 4-6).
References
(gore2022themultifacetedatpase pages 1-2): Emilia Gore, Thibaut Duparc, Annelise Genoux, Bertrand Perret, Souad Najib, and Laurent O. Martinez. The multifaceted atpase inhibitory factor 1 (if1) in energy metabolism reprogramming and mitochondrial dysfunction: a new player in age-associated disorders? Antioxidants & Redox Signaling, 37:370-393, Aug 2022. URL: https://doi.org/10.1089/ars.2021.0137, doi:10.1089/ars.2021.0137. This article has 43 citations and is from a domain leading peer-reviewed journal.
(gatto2022thef1foatpaseinhibitor pages 1-2): Cristina Gatto, Martina Grandi, Giancarlo Solaini, Alessandra Baracca, and Valentina Giorgio. The f1fo-atpase inhibitor protein if1 in pathophysiology. Frontiers in Physiology, Aug 2022. URL: https://doi.org/10.3389/fphys.2022.917203, doi:10.3389/fphys.2022.917203. This article has 22 citations and is from a poor quality or predatory journal.
(solaini2021thef1foatpaseinhibitor pages 1-5): Giancarlo Solaini, Gianluca Sgarbi, and Alessandra Baracca. The f1fo-atpase inhibitor, if1, is a critical regulator of energy metabolism in cancer cells. Biochemical Society transactions, 49:815-827, Apr 2021. URL: https://doi.org/10.1042/bst20200742, doi:10.1042/bst20200742. This article has 17 citations and is from a peer-reviewed journal.
(gore2022themultifacetedatpase pages 2-5): Emilia Gore, Thibaut Duparc, Annelise Genoux, Bertrand Perret, Souad Najib, and Laurent O. Martinez. The multifaceted atpase inhibitory factor 1 (if1) in energy metabolism reprogramming and mitochondrial dysfunction: a new player in age-associated disorders? Antioxidants & Redox Signaling, 37:370-393, Aug 2022. URL: https://doi.org/10.1089/ars.2021.0137, doi:10.1089/ars.2021.0137. This article has 43 citations and is from a domain leading peer-reviewed journal.
(cuezva2024theatpaseinhibitory pages 12-14): José M. Cuezva and Sonia Domínguez-Zorita. The atpase inhibitory factor 1 (if1) contributes to the warburg effect and is regulated by its phosphorylation in s39 by a protein kinase a-like activity. Cancers, 16:1014, Feb 2024. URL: https://doi.org/10.3390/cancers16051014, doi:10.3390/cancers16051014. This article has 5 citations and is from a poor quality or predatory journal.
(solaini2021thef1foatpaseinhibitor pages 5-8): Giancarlo Solaini, Gianluca Sgarbi, and Alessandra Baracca. The f1fo-atpase inhibitor, if1, is a critical regulator of energy metabolism in cancer cells. Biochemical Society transactions, 49:815-827, Apr 2021. URL: https://doi.org/10.1042/bst20200742, doi:10.1042/bst20200742. This article has 17 citations and is from a peer-reviewed journal.
(galber2023themitochondrialinhibitor pages 2-4): Chiara Galber, Simone Fabbian, Cristina Gatto, Martina Grandi, Stefania Carissimi, Manuel Jesus Acosta, Gianluca Sgarbi, Natascia Tiso, Francesco Argenton, Giancarlo Solaini, Alessandra Baracca, Massimo Bellanda, and Valentina Giorgio. The mitochondrial inhibitor if1 binds to the atp synthase oscp subunit and protects cancer cells from apoptosis. Cell Death & Disease, Jan 2023. URL: https://doi.org/10.1038/s41419-023-05572-y, doi:10.1038/s41419-023-05572-y. This article has 29 citations and is from a peer-reviewed journal.
(dominguezzorita2023themitochondrialatp pages 4-6): Sonia Domínguez-Zorita and José Cuezva. The mitochondrial atp synthase/if1 axis in cancer progression: targets for therapeutic intervention. Cancers, 15:3775, Jul 2023. URL: https://doi.org/10.3390/cancers15153775, doi:10.3390/cancers15153775. This article has 8 citations and is from a poor quality or predatory journal.
(grandi2024peptidestargetingthe pages 15-16): Martina Grandi, Simone Fabbian, Giancarlo Solaini, Alessandra Baracca, Massimo Bellanda, and Valentina Giorgio. Peptides targeting the if1–atp synthase complex modulate the permeability transition pore in cancer hela cells. International Journal of Molecular Sciences, 25:4655, Apr 2024. URL: https://doi.org/10.3390/ijms25094655, doi:10.3390/ijms25094655. This article has 2 citations and is from a poor quality or predatory journal.
(esparzamolto2021generationofmitochondrial pages 30-31): Pau B. Esparza-Moltó, Inés Romero-Carramiñana, Cristina Núñez De Arenas, Marta P. Pereira, Noelia Blanco, Beatriz Pardo, Georgina R. Bates, Carla Sánchez-Castillo, Rafael Artuch, Michael P. Murphy, José A. Esteban, and José M. Cuezva. Generation of mitochondrial reactive oxygen species is controlled by atpase inhibitory factor 1 and regulates cognition. Text, May 2021. URL: https://doi.org/10.17863/cam.70424, doi:10.17863/cam.70424. This article has 39 citations and is from a peer-reviewed journal.
id: Q9UII2
gene_symbol: ATP5IF1
product_type: PROTEIN
status: COMPLETE
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: >-
ATP5IF1 (also known as IF1 or ATPIF1) encodes the mitochondrial ATPase inhibitor,
a small nuclear-encoded protein that reversibly inhibits the F1Fo-ATP synthase
(complex V) to prevent wasteful ATP hydrolysis when the mitochondrial membrane
potential collapses (e.g., during ischemia or hypoxia). IF1 is active as an
antiparallel dimer at acidic pH (<6.7) and inactive as a tetramer at neutral pH.
The N-terminal inhibitory region (residues 26-52) binds the alpha/beta catalytic
interface of the F1 domain and contacts the gamma subunit to block rotary
catalysis. IF1 also binds the OSCP subunit, which protects cancer cells from
permeability transition pore-dependent apoptosis. Phosphorylation at Ser39 by
a mitochondrial PKA-like activity inactivates IF1. The protein is overexpressed
in many cancers and contributes to the glycolytic Warburg phenotype. IF1 also
indirectly regulates heme synthesis in erythroid tissues and promotes ATP synthase
dimerization, which influences cristae morphology.
alternative_products:
- name: '1'
id: Q9UII2-1
- name: '2'
id: Q9UII2-2
sequence_note: VSP_041417
- name: '3'
id: Q9UII2-3
sequence_note: VSP_041418
existing_annotations:
# ============================================================
# IBA (phylogenetic inference) annotations
# ============================================================
- term:
id: GO:0005737
label: cytoplasm
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
IBA annotation for cytoplasm based on phylogenetic inference. While IF1 is
primarily a mitochondrial matrix protein, the precursor form is synthesized
in the cytoplasm before import. The IBA also includes plant orthologs (TAIR
locus) and bovine P01096, suggesting broad conservation. However, cytoplasm
is a very general CC term and the primary active localization of IF1 is
mitochondrial.
action: REMOVE
reason: >-
The GOA qualifier is is_active_in, and the available evidence supports
cytosolic synthesis/import transit rather than ATP5IF1 being active in
cytoplasm. The functional location of IF1 is mitochondrial, especially the
matrix-facing F1Fo-ATP synthase context.
supported_by:
- reference_id: PMID:10664857
supporting_text: "cDNA coding the human homolog of the inhibitor protein was isolated and sequenced"
- term:
id: GO:0005739
label: mitochondrion
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
IBA annotation for mitochondrion based on phylogenetic inference across
the ATPase inhibitor family. This is the primary active localization of IF1.
action: ACCEPT
reason: >-
Mitochondrial localization is the core cellular compartment for IF1. The
mature protein functions in the mitochondrial matrix where it binds the F1
catalytic domain of ATP synthase. This is supported by multiple experimental
studies (PMID:12110673, PMID:35926043) and UniProt annotation.
supported_by:
- reference_id: PMID:12110673
supporting_text: "IF(1) could be co-isolated with F(1)F(0) when the immunocapture procedure was carried out at pH 6.5 but was absent when the ATP synthase was isolated at pH 8.0"
- term:
id: GO:0006783
label: heme biosynthetic process
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
IBA annotation for heme biosynthetic process based on phylogenetic inference
from mouse (MGI:1196457) and zebrafish (ZFIN:ZDB-GENE-070410-36) orthologs.
Shah et al. (2012, PMID:23135403) demonstrated that Atpif1 regulates heme
synthesis in developing erythroblasts by modulating mitochondrial pH and
redox potential, allowing FECH to catalyze iron incorporation into
protoporphyrin IX.
action: KEEP_AS_NON_CORE
reason: >-
This is a genuine but indirect role of IF1. The protein does not directly
participate in heme biosynthetic enzymology; rather, by inhibiting ATP
hydrolysis, IF1 maintains mitochondrial pH and redox conditions favorable
for FECH activity. UniProt explicitly states: "Indirectly acts as a
regulator of heme synthesis in erythroid tissues: regulates heme synthesis
by modulating the mitochondrial pH and redox potential, allowing FECH to
efficiently catalyze the incorporation of iron into protoporphyrin IX to
produce heme" (PMID:23135403). This is a secondary consequence of its
primary ATPase inhibitor activity, relevant mainly in erythroid tissues.
supported_by:
- reference_id: PMID:23135403
supporting_text: "Mitochondrial Atpif1 regulates haem synthesis in developing erythroblasts"
- term:
id: GO:0030218
label: erythrocyte differentiation
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
IBA annotation for erythrocyte differentiation based on phylogenetic
inference from mouse and zebrafish orthologs. The evidence comes from
PMID:23135403 showing that Atpif1 is required for proper heme synthesis
during erythroid development.
action: KEEP_AS_NON_CORE
reason: >-
Like heme biosynthesis, erythrocyte differentiation is an indirect
downstream consequence of IF1's ATPase inhibitor activity. IF1 is not
an erythroid-specific transcription factor or signaling molecule; it
supports erythropoiesis by maintaining mitochondrial conditions needed
for heme synthesis. This represents a tissue-specific pleiotropic effect
rather than a core molecular function.
supported_by:
- reference_id: PMID:23135403
supporting_text: "Mitochondrial Atpif1 regulates haem synthesis in developing erythroblasts"
- term:
id: GO:0042030
label: ATPase inhibitor activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
IBA annotation for ATPase inhibitor activity based on phylogenetic inference
across the ATPase inhibitor family (bovine P01096, rat RGD:2181, and human
Q9UII2). This is the defining molecular function of IF1.
action: ACCEPT
reason: >-
ATPase inhibitor activity is the core molecular function of ATP5IF1. The
protein is named for this activity and belongs to the ATPase inhibitor
family. IF1 inhibits the ATP hydrolase activity of F1Fo-ATP synthase,
preventing wasteful ATP consumption when the proton gradient collapses
(PMID:12110673, PMID:15528193, PMID:24005319). The IBA correctly reflects
the conserved function across mammals.
supported_by:
- reference_id: PMID:12110673
supporting_text: "The captured complex V displayed ATP hydrolysis activity that was fully oligomycin and inhibitor protein IF(1)-sensitive"
- reference_id: PMID:15528193
supporting_text: "IF1 protein bound to purified F(1) ATP synthase and inhibited F(1)-dependent ATP hydrolysis consistent with its reported activity in studies of mitochondria"
- reference_id: file:human/ATP5IF1/ATP5IF1-deep-research-falcon.md
supporting_text: "IF1 is a reversible, pH-sensitive inhibitor that primarily prevents wasteful ATP hydrolysis when Δψm collapses, but can also inhibit ATP synthesis in some contexts"
- term:
id: GO:0051117
label: ATPase binding
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
IBA annotation for ATPase binding based on phylogenetic inference. IF1
physically binds the F1 catalytic domain of ATP synthase, contacting the
alpha/beta subunit interface and the gamma subunit.
action: ACCEPT
reason: >-
ATPase binding is a core function that underlies the inhibitory activity
of IF1. Structural and biochemical studies demonstrate direct binding to
the F1 domain. The IBA annotation is consistent with the well-established
mechanism of IF1 action. Aggeler et al. (PMID:12110673) showed IF1
co-isolates with F1Fo at pH 6.5, and UniProt documents the binding
interface at the alpha-beta subunit interface (residues 26-52).
supported_by:
- reference_id: PMID:12110673
supporting_text: "IF(1) could be co-isolated with F(1)F(0) when the immunocapture procedure was carried out at pH 6.5"
# ============================================================
# IEA (electronic annotation) annotations
# ============================================================
- term:
id: GO:0005739
label: mitochondrion
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: >-
IEA annotation for mitochondrion based on combined automated methods
including InterPro domain (IPR007648) and UniProt subcellular location
annotation. Consistent with all other evidence for mitochondrial localization.
action: ACCEPT
reason: >-
This electronic annotation is consistent with the well-established
mitochondrial localization of IF1, supported by multiple experimental
evidence codes (IDA, HTP, HDA, ISS, TAS, IBA). The InterPro domain
IPR007648 (ATPase_inhibitor_mt) is specifically a mitochondrial domain.
- term:
id: GO:0042030
label: ATPase inhibitor activity
evidence_type: IEA
original_reference_id: GO_REF:0000002
review:
summary: >-
IEA annotation for ATPase inhibitor activity based on InterPro domain
IPR007648 mapping. This is the defining function of the protein family.
action: ACCEPT
reason: >-
The InterPro-based electronic annotation correctly identifies the core
molecular function. The ATPase_inhibitor_mt domain (IPR007648) is
directly associated with ATPase inhibitor activity, and this is the
primary function of IF1 supported by extensive experimental evidence.
# ============================================================
# Protein binding IPI annotations (high-throughput interactome studies)
# ============================================================
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:28514442
review:
summary: >-
IPI annotation for protein binding from the BioPlex 2.0 human interactome
study (Huttlin et al. 2017). The WITH column indicates binding to P06576
(ATP5F1B, the beta subunit of F1-ATP synthase). This interaction is
biologically meaningful and well-established.
action: MODIFY
reason: >-
While the interaction with ATP5F1B (beta subunit) is real and reflects
the core mechanism of IF1, "protein binding" (GO:0005515) is uninformative.
The specific interaction with the beta subunit of ATP synthase is the
mechanistic basis of IF1's inhibitory function. A more specific term
should be used.
proposed_replacement_terms:
- id: GO:0140260
label: mitochondrial proton-transporting ATP synthase complex binding
supported_by:
- reference_id: PMID:28514442
supporting_text: "Architecture of the human interactome defines protein communities and disease networks"
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:30021884
review:
summary: >-
IPI annotation for protein binding from a crosslinking mass spectrometry
study of intact cell nuclei (Fasci et al. 2018). The WITH column indicates
binding to P06576 (ATP5F1B). This study focused on histone interactions
in nuclei, making ATP5IF1 detection likely a contaminant or crossreactive
hit.
action: REMOVE
reason: >-
This intact-nuclei XL-MS study does not provide reliable support for a
physiological mitochondrial ATP5IF1-ATP5F1B interaction. The core ATP synthase
complex binding function is already supported by direct mitochondrial evidence
from other publications, so this nuclear-context protein-binding row should
not be modified into that term.
supported_by:
- reference_id: PMID:30021884
supporting_text: "Histone Interaction Landscapes Visualized by Crosslinking Mass Spectrometry in Intact Cell Nuclei"
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:32296183
review:
summary: >-
IPI annotation for protein binding from the HuRI reference binary
interactome map (Luck et al. 2020). The WITH column indicates binding
to Q9HAQ2 (KIF9) and Q9NRD5 (PICK1). These are high-throughput Y2H
hits with no clear biological relevance to IF1's known function.
action: MARK_AS_OVER_ANNOTATED
reason: >-
KIF9 and PICK1 are not known to have any functional relationship with
mitochondrial ATP synthase or IF1's inhibitory activity. These likely
represent false-positive or non-physiological interactions from
high-throughput Y2H screening. The generic "protein binding" term
combined with HTP interactome partners of unclear relevance makes
this an over-annotation.
supported_by:
- reference_id: PMID:32296183
supporting_text: "A reference map of the human binary protein interactome"
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:32807793
review:
summary: >-
IPI annotation for protein binding from Sharanek et al. 2020, studying
mitochondrial OSMR in glioblastoma. The WITH column indicates binding to
Q99650 (OSMR). The paper found OSMR localizes to mitochondria and
interacts with complex I, and IF1 was detected as an interactor.
action: MARK_AS_OVER_ANNOTATED
reason: >-
While OSMR was shown to localize to mitochondria, the interaction with
IF1 is likely an indirect association within the mitochondrial inner
membrane protein network rather than a direct functional interaction.
The paper focuses on OSMR-complex I interactions, not IF1. The generic
"protein binding" term does not capture any meaningful functional
relationship.
supported_by:
- reference_id: PMID:32807793
supporting_text: "OSMR controls glioma stem cell respiration and confers resistance of glioblastoma to ionizing radiation"
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:32814053
review:
summary: >-
IPI annotation for protein binding from a neurodegenerative disease
interactome mapping study (Haenig et al. 2020). The WITH column lists
many diverse proteins (PMP22, DMWD, NEFL, TOR1A, KLF11, DNAJB6, DNM2,
FGFR3, GLE1, GRN, GSN, HRAS, A2M, ADRB2, MECP2, NUP58, SPRED1,
P28329-3/CHAT, P28799-2/GRN). These represent high-throughput Y2H hits
from a disease-focused interactome screen.
action: MARK_AS_OVER_ANNOTATED
reason: >-
This is a large-scale interactome study focused on neurodegenerative
disease proteins. The vast majority of these interactors (NEFL, MECP2,
HRAS, FGFR3, GSN, A2M, etc.) have no plausible direct functional
relationship with mitochondrial IF1. These are likely false positives
or non-physiological interactions from Y2H. The sheer number and
diversity of partners argues against specificity. "Protein binding"
is already uninformative and these interactions do not add functional
insight.
supported_by:
- reference_id: PMID:32814053
supporting_text: "Interactome Mapping Provides a Network of Neurodegenerative Disease Proteins and Uncovers Widespread Protein Aggregation in Affected Brains"
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:33961781
review:
summary: >-
IPI annotation for protein binding from BioPlex 3.0 (Huttlin et al. 2021).
The WITH column indicates binding to P06576 (ATP5F1B, beta subunit of
F1-ATP synthase). This is the same core interaction as PMID:28514442.
action: MODIFY
reason: >-
The interaction with ATP5F1B is the core functional binding partner of
IF1 and is well-established. However, "protein binding" is uninformative.
A more specific term should be used.
proposed_replacement_terms:
- id: GO:0140260
label: mitochondrial proton-transporting ATP synthase complex binding
supported_by:
- reference_id: PMID:33961781
supporting_text: "Dual proteome-scale networks reveal cell-specific remodeling of the human interactome"
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:40205054
review:
summary: >-
IPI annotation for protein binding from Schaffer et al. 2025 multimodal
cell maps study. The WITH column indicates binding to P06576 (ATP5F1B).
Again, the same core interaction with the beta subunit.
action: MODIFY
reason: >-
Same rationale as for PMID:28514442 and PMID:33961781. The interaction
with ATP5F1B is real but "protein binding" is uninformative. A more
specific MF term exists.
proposed_replacement_terms:
- id: GO:0140260
label: mitochondrial proton-transporting ATP synthase complex binding
supported_by:
- reference_id: PMID:40205054
supporting_text: "Multimodal cell maps as a foundation for structural and functional genomics"
# ============================================================
# IEA annotations from Ensembl Compara
# ============================================================
- term:
id: GO:0006783
label: heme biosynthetic process
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: >-
IEA annotation for heme biosynthetic process transferred from mouse
ortholog O35143 via Ensembl Compara. Consistent with the IBA annotation
and the experimental evidence from Shah et al. (PMID:23135403).
action: KEEP_AS_NON_CORE
reason: >-
This electronic transfer from the mouse ortholog is consistent with
the IBA annotation and PMID:23135403 showing IF1 regulates heme
synthesis indirectly. Same rationale as the IBA annotation: this is
a genuine but non-core function.
- term:
id: GO:0030218
label: erythrocyte differentiation
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: >-
IEA annotation for erythrocyte differentiation transferred from mouse
ortholog O35143 via Ensembl Compara. Consistent with the IBA annotation
and PMID:23135403.
action: KEEP_AS_NON_CORE
reason: >-
Same rationale as the IBA annotation for this term: erythrocyte
differentiation is a tissue-specific downstream consequence of IF1's
ATPase inhibitor activity supporting heme synthesis.
# ============================================================
# IMP (mutant phenotype) annotations from PMID:24005319
# ============================================================
- term:
id: GO:0045732
label: positive regulation of protein catabolic process
evidence_type: IMP
original_reference_id: PMID:24005319
review:
summary: >-
IMP annotation from Lefebvre et al. 2013 genome-wide RNAi screen that
identified ATPIF1 as essential for PARK2 recruitment and mitophagy. ATPIF1
knockdown blocked PARK2-dependent ubiquitination and subsequent mitophagy
of damaged mitochondria, which involves protein catabolism of
ubiquitinated mitochondrial substrates.
action: KEEP_AS_NON_CORE
reason: >-
The connection to protein catabolism is through the PINK1-PARK2 mitophagy
pathway. ATPIF1 promotes mitochondrial depolarization during uncoupling,
which triggers PARK2 recruitment and ubiquitination of mitochondrial
proteins for proteasomal/autophagic degradation. This is an indirect
downstream consequence of IF1's primary ATPase inhibitor activity.
While experimentally demonstrated, it is not a core function.
supported_by:
- reference_id: PMID:24005319
supporting_text: "we identified ATPase inhibitory factor 1 (ATPIF1/IF1) as essential for PARK2 recruitment and mitophagy in cultured cells"
- term:
id: GO:1905707
label: negative regulation of mitochondrial ATP synthesis coupled proton transport
evidence_type: IMP
original_reference_id: PMID:24005319
review:
summary: >-
IMP annotation from Lefebvre et al. 2013 showing that ATPIF1 blocks
ATP synthase from running in reverse (as an ATPase) during uncoupling.
The annotation captures the process-level consequence of IF1's ATPase
inhibitor activity on ATP synthesis coupled proton transport.
action: ACCEPT
reason: >-
This annotation correctly captures the core biological process function
of IF1. During mitochondrial uncoupling, the F1Fo-ATP synthase can
reverse to hydrolyze ATP and pump protons. IF1 inhibits this reversal,
effectively negatively regulating the overall ATP synthesis coupled
proton transport process. Lefebvre et al. showed "ATPIF1 promotes
collapse of delta-psi and activation of the PINK-PARK2 mitophagy
pathway by blocking the ATPase activity of the F1-Fo ATP synthase"
(PMID:24005319).
supported_by:
- reference_id: PMID:24005319
supporting_text: "During uncoupling, ATPIF1 promotes collapse of ΔΨ and activation of the PINK-PARK2 mitophagy pathway by blocking the ATPase activity of the F 1-Fo ATP synthase"
# ============================================================
# IDA annotations from various sources
# ============================================================
- term:
id: GO:0005739
label: mitochondrion
evidence_type: IDA
original_reference_id: GO_REF:0000052
review:
summary: >-
IDA annotation for mitochondrion based on curation of immunofluorescence
data (Human Protein Atlas). Direct visualization of IF1 in mitochondria.
action: ACCEPT
reason: >-
Direct immunofluorescence evidence for mitochondrial localization is
consistent with all other evidence. HPA data provides independent
confirmation of the core localization.
- term:
id: GO:0002931
label: response to ischemia
evidence_type: IDA
original_reference_id: PMID:35926043
review:
summary: >-
IDA annotation from Wyant et al. 2022 (Science) showing that ATPIF1 is
involved in ischemic protection. GPR35 activation led to ATPIF1-dependent
ATP synthase dimerization that prevented ATP loss during ischemia. The
study demonstrated that "Activated GPR35, in an ATPIF1-dependent and
pertussis toxin-sensitive manner, induced ATP synthase dimerization,
which prevented ATP loss upon ischemia."
action: KEEP_AS_NON_CORE
reason: >-
Response to ischemia is biologically important and experimentally
demonstrated, but it represents a physiological context in which IF1's
primary ATPase inhibitor function is deployed, rather than the core
function itself. IF1's role in ischemic protection is a consequence
of its ability to prevent ATP hydrolysis when the proton gradient
collapses. This is a key physiological role but secondary to the
molecular function.
supported_by:
- reference_id: PMID:35926043
supporting_text: "Activated GPR35, in an ATPIF1-dependent and pertussis toxin-sensitive manner, induced ATP synthase dimerization, which prevented ATP loss upon ischemia"
- term:
id: GO:0010667
label: negative regulation of cardiac muscle cell apoptotic process
evidence_type: IDA
original_reference_id: PMID:35926043
review:
summary: >-
IDA annotation from Wyant et al. 2022 showing that ATPIF1-dependent
ATP synthase dimerization contributes to cardiac protection during
ischemia. By preventing ATP depletion, IF1 protects cardiac cells
from apoptosis during ischemic stress.
action: UNDECIDED
reason: >-
The accessible evidence supports GPR35/ATPIF1-dependent ATP synthase
dimerization and ATP preservation during ischemia, but the cached support
does not directly establish negative regulation of cardiac muscle cell
apoptosis. Treat this as undecided until direct apoptosis evidence from the
paper is available.
supported_by:
- reference_id: PMID:35926043
supporting_text: "Activated GPR35, in an ATPIF1-dependent and pertussis toxin-sensitive manner, induced ATP synthase dimerization, which prevented ATP loss upon ischemia"
# ============================================================
# TAS annotation for ATPase inhibitor activity
# ============================================================
- term:
id: GO:0042030
label: ATPase inhibitor activity
evidence_type: TAS
original_reference_id: PMID:24005319
review:
summary: >-
TAS annotation for ATPase inhibitor activity based on Lefebvre et al.
2013. The paper describes ATPIF1 as "blocking the ATPase activity of
the F1-Fo ATP synthase" during uncoupling.
action: ACCEPT
reason: >-
ATPase inhibitor activity is the core molecular function. This TAS
annotation is consistent with all other evidence for this function.
The paper explicitly describes ATPIF1 blocking ATPase activity.
supported_by:
- reference_id: PMID:24005319
supporting_text: "During uncoupling, ATPIF1 promotes collapse of ΔΨ and activation of the PINK-PARK2 mitophagy pathway by blocking the ATPase activity of the F 1-Fo ATP synthase"
# ============================================================
# HTP annotation for mitochondrion
# ============================================================
- term:
id: GO:0005739
label: mitochondrion
evidence_type: HTP
original_reference_id: PMID:34800366
review:
summary: >-
HTP annotation for mitochondrion from Morgenstern et al. 2021, a
quantitative high-confidence human mitochondrial proteome study.
ATP5IF1 was identified as a high-confidence mitochondrial protein.
action: ACCEPT
reason: >-
This high-throughput proteomics study provides quantitative evidence
for mitochondrial localization. Consistent with all other evidence
codes for this localization.
supported_by:
- reference_id: PMID:34800366
supporting_text: "Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context"
# ============================================================
# ISS annotations transferred from bovine ortholog P01096
# ============================================================
- term:
id: GO:1905707
label: negative regulation of mitochondrial ATP synthesis coupled proton transport
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: >-
ISS annotation transferred from bovine ortholog P01096. The bovine IF1
was the first characterized member of this family and shares high
sequence conservation with human IF1. The function is well-conserved.
action: ACCEPT
reason: >-
This ISS annotation is consistent with the IMP annotation from
PMID:24005319 for the same GO term. The bovine ortholog is the
best-studied member of this family, and the transfer is appropriate
given high sequence conservation and shared function.
- term:
id: GO:0032991
label: protein-containing complex
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: >-
ISS annotation indicating IF1 is part of a protein-containing complex,
transferred from bovine ortholog P01096. IF1 forms homodimers and
associates with the F1Fo-ATP synthase complex.
action: REMOVE
reason: >-
While IF1 is indeed part of protein complexes (homodimers and the
IF1-ATP synthase complex), "protein-containing complex" is too generic and
there is no appropriate same-aspect CC replacement here. The relevant biology
is already captured by more specific annotations: mitochondrial localization
and the supported MF annotation for mitochondrial proton-transporting ATP
synthase complex binding (GO:0140260).
- term:
id: GO:0042802
label: identical protein binding
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: >-
ISS annotation for identical protein binding (homodimerization)
transferred from bovine ortholog P01096. IF1 forms antiparallel
dimers at acidic pH, which is the active inhibitory form, and
homotetramers at neutral pH, which is the inactive form.
action: ACCEPT
reason: >-
Homodimerization is a critical regulatory mechanism for IF1.
UniProt states: "Homodimer; represents the active form and is
present at a pH value below 6.5. Homotetramer; represents the
inactive form and is present at a pH value above 7.0." The
antiparallel coiled-coil dimer (residues 74-106) is essential
for the inhibitory mechanism. While "identical protein binding"
is somewhat generic, it accurately captures the homodimerization
property.
supported_by:
- reference_id: PMID:12110673
supporting_text: "IF(1) could be co-isolated with F(1)F(0) when the immunocapture procedure was carried out at pH 6.5 but was absent when the ATP synthase was isolated at pH 8.0"
# ============================================================
# IDA for ATP synthase complex binding
# ============================================================
- term:
id: GO:0140260
label: mitochondrial proton-transporting ATP synthase complex binding
evidence_type: IDA
original_reference_id: PMID:12110673
review:
summary: >-
IDA annotation for direct binding to the mitochondrial ATP synthase
complex, from Aggeler et al. 2002. The study demonstrated
co-immunoprecipitation of IF1 with F1Fo-ATP synthase from human
heart mitochondria in a pH-dependent manner.
action: ACCEPT
reason: >-
This is a core molecular function annotation. Aggeler et al. directly
demonstrated that IF1 co-purifies with immunocaptured F1Fo-ATP synthase
at pH 6.5 but not at pH 8.0, confirming direct pH-dependent binding.
The captured complex could be inhibited >90% by recombinant IF1 and
activated >10-fold by pH 8.0 release.
supported_by:
- reference_id: PMID:12110673
supporting_text: "IF(1) could be co-isolated with F(1)F(0) when the immunocapture procedure was carried out at pH 6.5 but was absent when the ATP synthase was isolated at pH 8.0"
- reference_id: PMID:12110673
supporting_text: "Immunocaptured F(1)F(0) lacking IF(1) could be inhibited by more than 90% by addition of recombinant inhibitor protein"
# ============================================================
# IMP for mitophagy from PMID:24005319
# ============================================================
- term:
id: GO:1905091
label: positive regulation of type 2 mitophagy
evidence_type: IMP
original_reference_id: PMID:24005319
review:
summary: >-
IMP annotation from Lefebvre et al. 2013 genome-wide RNAi screen.
ATPIF1 was identified as essential for PARK2 recruitment to depolarized
mitochondria and subsequent mitophagy. ATPIF1 promotes mitochondrial
depolarization by blocking reverse ATP synthase activity, which is
required for PINK1 stabilization and PARK2 recruitment.
action: KEEP_AS_NON_CORE
reason: >-
Mitophagy regulation is an experimentally supported but indirect
consequence of IF1's primary ATPase inhibitor activity. IF1 promotes
mitophagy by ensuring complete mitochondrial depolarization during
uncoupling (by preventing ATP hydrolysis-driven proton pumping),
which allows PINK1 accumulation and PARK2 recruitment. This is a
downstream biological process rather than a core function.
supported_by:
- reference_id: PMID:24005319
supporting_text: "we identified ATPase inhibitory factor 1 (ATPIF1/IF1) as essential for PARK2 recruitment and mitophagy in cultured cells"
- reference_id: PMID:24005319
supporting_text: "Restoration of ATPIF1 in Rho0 cells, which lack mtDNA and a functional electron transport chain, lowers ΔΨ and triggers PARK2 recruitment"
# ============================================================
# IPI for enzyme binding from PMID:21106936
# ============================================================
- term:
id: GO:0019899
label: enzyme binding
evidence_type: IPI
original_reference_id: PMID:21106936
review:
summary: >-
IPI annotation for enzyme binding from Freeman et al. 2011. The study
focused on thymosin beta-4 (Tbeta4) as a regulator of cell surface ATP
synthase in endothelial cells. IF1 was described as having structural
similarity to Tbeta4 in silico. The WITH column indicates P06576
(ATP5F1B) and P25705 (ATP5F1A), the beta and alpha subunits of F1-ATP
synthase.
action: MODIFY
reason: >-
The binding partners (ATP5F1A and ATP5F1B, the alpha and beta subunits
of F1-ATP synthase) are correct and represent the core binding target
of IF1. However, "enzyme binding" is too generic. The specific binding
to the ATP synthase complex is well-characterized and a more specific
term exists.
proposed_replacement_terms:
- id: GO:0140260
label: mitochondrial proton-transporting ATP synthase complex binding
supported_by:
- reference_id: PMID:21106936
supporting_text: "we identified common amphiphilic alpha-helical structural similarities between beta-thymosins and the inhibitory factor 1 (IF1), an inhibitor of ATP synthase hydrolysis"
# ============================================================
# IMP annotations from PMID:24005319 (continued)
# ============================================================
- term:
id: GO:1903747
label: regulation of protein localization to mitochondrion
evidence_type: IMP
original_reference_id: PMID:24005319
review:
summary: >-
IMP annotation from Lefebvre et al. 2013. ATPIF1 knockdown prevented
PARK2 translocation to mitochondria. By promoting mitochondrial
depolarization (blocking reverse ATP synthase), ATPIF1 enables the
PINK1-dependent recruitment of PARK2 to damaged mitochondria.
action: KEEP_AS_NON_CORE
reason: >-
This annotation captures a specific aspect of the mitophagy pathway:
IF1-dependent regulation of PARK2 localization to mitochondria. While
experimentally supported by the RNAi screen, this is an indirect
downstream effect. IF1 does not directly regulate protein localization
machinery; it enables PARK2 recruitment by ensuring mitochondrial
depolarization through its ATPase inhibitor activity.
supported_by:
- reference_id: PMID:24005319
supporting_text: "we identified ATPase inhibitory factor 1 (ATPIF1/IF1) as essential for PARK2 recruitment and mitophagy in cultured cells"
- term:
id: GO:0051882
label: mitochondrial depolarization
evidence_type: IMP
original_reference_id: PMID:24005319
review:
summary: >-
IMP annotation from Lefebvre et al. 2013. ATPIF1 promotes collapse
of the mitochondrial membrane potential during uncoupling by blocking
the reverse ATPase activity that would otherwise maintain membrane
potential by pumping protons.
action: ACCEPT
reason: >-
Mitochondrial depolarization is a direct and proximal consequence of
IF1's core ATPase inhibitor activity. When the electron transport
chain fails or is uncoupled, ATP synthase reverses to hydrolyze ATP
and pump protons, partially maintaining membrane potential. IF1 blocks
this reversal, allowing complete depolarization. This is a direct
functional outcome and closely tied to the core mechanism. The paper
states: "During uncoupling, ATPIF1 promotes collapse of delta-psi...
by blocking the ATPase activity of the F1-Fo ATP synthase."
supported_by:
- reference_id: PMID:24005319
supporting_text: "During uncoupling, ATPIF1 promotes collapse of ΔΨ and activation of the PINK-PARK2 mitophagy pathway by blocking the ATPase activity of the F 1-Fo ATP synthase"
- reference_id: PMID:24005319
supporting_text: "Restoration of ATPIF1 in Rho0 cells, which lack mtDNA and a functional electron transport chain, lowers ΔΨ and triggers PARK2 recruitment"
# ============================================================
# HDA annotation for mitochondrion
# ============================================================
- term:
id: GO:0005739
label: mitochondrion
evidence_type: HDA
original_reference_id: PMID:20833797
review:
summary: >-
HDA annotation for mitochondrial localization from Zhao et al. 2011,
a phosphoproteomics study of functional mitochondria isolated from
human muscle. IF1 was detected in the mitochondrial phosphoproteome.
action: ACCEPT
reason: >-
This high-throughput direct assay evidence for mitochondrial
localization is consistent with all other evidence. The protein
was identified in isolated mitochondria from human skeletal muscle.
supported_by:
- reference_id: PMID:20833797
supporting_text: "Phosphoproteome analysis of functional mitochondria isolated from resting human muscle reveals extensive phosphorylation of inner membrane protein complexes and enzymes"
# ============================================================
# ISS for ATPase inhibitor activity
# ============================================================
- term:
id: GO:0042030
label: ATPase inhibitor activity
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: >-
ISS annotation for ATPase inhibitor activity transferred from bovine
ortholog P01096. The bovine IF1 is the best-characterized member of
this protein family.
action: ACCEPT
reason: >-
This is the core molecular function, and the transfer from the bovine
ortholog is appropriate given high sequence conservation and identical
function. Consistent with IDA and IBA annotations for the same term.
# ============================================================
# IDA annotations from PMID:12110673
# ============================================================
- term:
id: GO:0005739
label: mitochondrion
evidence_type: IDA
original_reference_id: PMID:12110673
review:
summary: >-
IDA annotation for mitochondrial localization from Aggeler et al. 2002.
IF1 was identified as a subunit of the immunocaptured F1Fo-ATP synthase
complex from human heart mitochondria and fibroblasts.
action: ACCEPT
reason: >-
Direct experimental evidence from immunocapture of mitochondrial ATP
synthase complex. IF1 was detected with specific antibody and
co-purified with the complex from mitochondria.
supported_by:
- reference_id: PMID:12110673
supporting_text: "The immunoprecipitated F(1)F(0) contained a full complement of subunits that were identified with specific antibodies against five of the subunits (alpha, beta, OSCP, d, and IF(1))"
- term:
id: GO:0042030
label: ATPase inhibitor activity
evidence_type: IDA
original_reference_id: PMID:12110673
review:
summary: >-
IDA annotation for ATPase inhibitor activity from Aggeler et al. 2002.
The study directly demonstrated that recombinant IF1 inhibited ATP
hydrolysis by immunocaptured F1Fo-ATP synthase by >90%, and that
removal of IF1 at pH 8.0 activated the enzyme >10-fold.
action: ACCEPT
reason: >-
This is direct experimental evidence for the core molecular function.
The quantitative inhibition data (>90% inhibition by recombinant IF1,
>10-fold activation upon IF1 release) provides strong support for
ATPase inhibitor activity.
supported_by:
- reference_id: PMID:12110673
supporting_text: "Immunocaptured F(1)F(0) lacking IF(1) could be inhibited by more than 90% by addition of recombinant inhibitor protein, and conversely, F(1)F(0) containing IF(1) could be activated more than 10-fold by brief exposure to pH 8.0, inducing the release of inhibitor protein"
# ============================================================
# Annotations from PMID:15528193 (Burwick et al. 2005)
# ============================================================
- term:
id: GO:0001525
label: angiogenesis
evidence_type: TAS
original_reference_id: PMID:15528193
review:
summary: >-
TAS annotation for angiogenesis from Burwick et al. 2005. The study
explored IF1's effect on cell surface ATP synthase in endothelial cells
and its relationship with angiostatin-mediated anti-angiogenesis. IF1
was proposed to have a "protective role for EC in the tumor microenvironment"
that could be overridden by angiostatin.
action: KEEP_AS_NON_CORE
reason: >-
The paper studied IF1 in the context of cell surface ATP synthase and
angiostatin, concluding that IF1 is NOT an angiostatin mimetic and
only "slightly inhibited cell proliferation compared with angiostatin."
The connection to angiogenesis is indirect through the cell surface
ATP synthase-angiostatin axis. This is a peripheral, non-core function
related to the unusual cell surface localization of IF1/ATP synthase,
not the primary mitochondrial function.
supported_by:
- reference_id: PMID:15528193
supporting_text: "We propose that IF1 is not an angiostatin mimetic, but it can serve a protective role for EC in the tumor microenvironment"
- reference_id: PMID:15528193
supporting_text: "IF1 did not inhibit EC differentiation to form tubes and only slightly inhibited cell proliferation compared with angiostatin"
- term:
id: GO:0001937
label: negative regulation of endothelial cell proliferation
evidence_type: IDA
original_reference_id: PMID:15528193
review:
summary: >-
IDA annotation from Burwick et al. 2005 showing that exogenous IF1
"only slightly inhibited cell proliferation compared with angiostatin."
The paper explicitly states the effect was minor.
action: MARK_AS_OVER_ANNOTATED
reason: >-
The paper itself states IF1 "only slightly inhibited cell proliferation
compared with angiostatin." This is a marginal effect observed with
exogenous IF1 on cell surface ATP synthase, not the protein's primary
function. The anti-proliferative effect was weak and the authors
concluded IF1 is "not an angiostatin mimetic." This represents an
over-annotation of a minor experimental observation.
supported_by:
- reference_id: PMID:15528193
supporting_text: "IF1 did not inhibit EC differentiation to form tubes and only slightly inhibited cell proliferation compared with angiostatin"
- term:
id: GO:0005516
label: calmodulin binding
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: >-
ISS annotation for calmodulin binding transferred from bovine ortholog
P01096. Calmodulin has been reported to interact with IF1 in bovine
systems, potentially regulating its activity or oligomeric state.
action: UNDECIDED
reason: >-
The calmodulin binding annotation is transferred from the bovine
ortholog. While there is some evidence for calmodulin-IF1 interaction
in bovine systems, the physiological significance and whether this
applies to human IF1 is not well-established in the publications
available for review. The core regulatory mechanisms of IF1 (pH-dependent
oligomerization and Ser39 phosphorylation) are well-documented, but
calmodulin regulation is less certain. Without access to the primary
bovine literature supporting this claim, this should remain undecided.
- term:
id: GO:0005739
label: mitochondrion
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: >-
ISS annotation for mitochondrion transferred from bovine ortholog
P01096. Consistent with all other evidence for mitochondrial localization.
action: ACCEPT
reason: >-
Mitochondrial localization is well-established for IF1 across species.
This ISS transfer is consistent with IDA, IBA, IEA, HTP, HDA, and
TAS evidence for the same localization.
- term:
id: GO:0009986
label: cell surface
evidence_type: IDA
original_reference_id: PMID:15528193
review:
summary: >-
IDA annotation for cell surface localization from Burwick et al. 2005.
The study showed IF1 interacting with cell surface F1-ATP synthase on
endothelial cells. The paper demonstrated IF1 binding to purified F1
and its effects on cell surface ATP hydrolysis.
action: KEEP_AS_NON_CORE
reason: >-
Cell surface localization of IF1 (and ATP synthase) has been reported
on endothelial cells. While the primary localization of IF1 is
mitochondrial, the cell surface localization appears to be a genuine
but secondary location. The biological significance of cell surface
IF1 is debated, and it may represent ectopic localization in certain
cell types rather than a core function.
supported_by:
- reference_id: PMID:15528193
supporting_text: "IF1 protein bound to purified F(1) ATP synthase and inhibited F(1)-dependent ATP hydrolysis consistent with its reported activity in studies of mitochondria"
- term:
id: GO:0042030
label: ATPase inhibitor activity
evidence_type: IDA
original_reference_id: PMID:15528193
review:
summary: >-
IDA annotation for ATPase inhibitor activity from Burwick et al. 2005.
The study confirmed IF1 inhibited F1-dependent ATP hydrolysis both
with purified enzyme and on the cell surface.
action: ACCEPT
reason: >-
The paper directly demonstrates ATPase inhibitor activity, consistent
with the core function. IF1 inhibited ATP hydrolysis but notably
"did not inhibit ATP synthesis" on the cell surface, confirming
its specific ATPase (hydrolysis) inhibitor activity.
supported_by:
- reference_id: PMID:15528193
supporting_text: "IF1 protein bound to purified F(1) ATP synthase and inhibited F(1)-dependent ATP hydrolysis consistent with its reported activity in studies of mitochondria"
- reference_id: PMID:15528193
supporting_text: "IF1 inhibited ATP hydrolysis but not ATP synthesis, in contrast to angiostatin, which inhibited both"
- term:
id: GO:0043532
label: angiostatin binding
evidence_type: IDA
original_reference_id: PMID:15528193
review:
summary: >-
IDA annotation for angiostatin binding from Burwick et al. 2005. The
study showed that "angiostatin blocks IF1 binding to ATP synthase and
abolishes its ability to conserve ATP," suggesting overlapping binding
sites. However, this demonstrates competition for ATP synthase binding,
not necessarily direct IF1-angiostatin binding.
action: UNDECIDED
reason: >-
The paper demonstrates that angiostatin and IF1 compete for binding
to ATP synthase, which implies overlapping binding sites on the enzyme
rather than direct IF1-angiostatin binding. The statement "there is
a relationship between the binding sites of IF1 and angiostatin on
ATP synthase" supports competition, not direct binding. Without
access to the full text to determine whether direct binding was
actually demonstrated (rather than competition), this remains unclear.
supported_by:
- reference_id: PMID:15528193
supporting_text: "angiostatin blocks IF1 binding to ATP synthase and abolishes its ability to conserve ATP"
- reference_id: PMID:15528193
supporting_text: "These data suggest that there is a relationship between the binding sites of IF1 and angiostatin on ATP synthase"
- term:
id: GO:0051117
label: ATPase binding
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: >-
ISS annotation for ATPase binding transferred from bovine ortholog
P01096. Consistent with the IBA and IDA annotations for this term.
action: ACCEPT
reason: >-
ATPase binding is a core function, and this ISS transfer from the
bovine ortholog is well-supported by multiple experimental evidence
types for the same term.
- term:
id: GO:0051117
label: ATPase binding
evidence_type: IDA
original_reference_id: PMID:15528193
review:
summary: >-
IDA annotation for ATPase binding from Burwick et al. 2005. The study
demonstrated direct binding of IF1 to purified F1 ATP synthase.
action: ACCEPT
reason: >-
The paper directly demonstrates IF1 binding to F1-ATP synthase. This
is a core function well-supported by multiple lines of evidence.
supported_by:
- reference_id: PMID:15528193
supporting_text: "IF1 protein bound to purified F(1) ATP synthase and inhibited F(1)-dependent ATP hydrolysis"
- term:
id: GO:0051346
label: negative regulation of hydrolase activity
evidence_type: IDA
original_reference_id: PMID:15528193
review:
summary: >-
IDA annotation for negative regulation of hydrolase activity from
Burwick et al. 2005. IF1 inhibited ATP hydrolysis activity of the
F1-ATP synthase both in purified form and on the cell surface.
action: ACCEPT
reason: >-
This annotation accurately captures the core process-level function
of IF1 at a somewhat general level. IF1 negatively regulates the
ATP hydrolase activity of F1Fo-ATP synthase. While GO:1905707
(negative regulation of mitochondrial ATP synthesis coupled proton
transport) is more specific, this term is also accurate as a broader
description of the mechanism.
supported_by:
- reference_id: PMID:15528193
supporting_text: "IF1 inhibited ATP hydrolysis but not ATP synthesis"
# ============================================================
# TAS annotations from PMID:10664857 (Ichikawa et al. 1999)
# ============================================================
- term:
id: GO:0004857
label: enzyme inhibitor activity
evidence_type: TAS
original_reference_id: PMID:10664857
review:
summary: >-
TAS annotation for enzyme inhibitor activity from Ichikawa et al. 1999,
the paper reporting the human cDNA sequence. The paper describes the
protein as "the ATPase inhibitor" based on sequence homology to the
bovine inhibitor protein.
action: MODIFY
reason: >-
While IF1 is indeed an enzyme inhibitor, "enzyme inhibitor activity"
(GO:0004857) is too general. The more specific term "ATPase inhibitor
activity" (GO:0042030) is already annotated and better captures the
specific function. This general term should be replaced with the
more specific one.
proposed_replacement_terms:
- id: GO:0042030
label: ATPase inhibitor activity
supported_by:
- reference_id: PMID:10664857
supporting_text: "cDNA coding the human homolog of the inhibitor protein was isolated and sequenced"
- term:
id: GO:0005739
label: mitochondrion
evidence_type: TAS
original_reference_id: PMID:10664857
review:
summary: >-
TAS annotation for mitochondrion from Ichikawa et al. 1999. The paper
describes the protein as "the mitochondrial precursor protein of the
ATPase inhibitor from humans."
action: ACCEPT
reason: >-
Mitochondrial localization is stated in the paper title and is consistent
with all other evidence. The paper describes the mitochondrial transit
peptide and identifies the protein as a mitochondrial ATPase inhibitor.
supported_by:
- reference_id: PMID:10664857
supporting_text: "cDNA coding the mitochondrial precursor protein of the ATPase inhibitor from humans"
- term:
id: GO:0006091
label: generation of precursor metabolites and energy
evidence_type: TAS
original_reference_id: PMID:10664857
review:
summary: >-
TAS annotation for generation of precursor metabolites and energy from
Ichikawa et al. 1999. This is a very broad biological process term
covering all of energy metabolism.
action: MODIFY
reason: >-
This term is too broad. IF1 does not generally participate in
"generation of precursor metabolites and energy" -- it specifically
inhibits ATP hydrolysis by the F1Fo-ATP synthase. The more specific
term GO:1905707 (negative regulation of mitochondrial ATP synthesis
coupled proton transport) better captures the actual process.
Alternatively, GO:1903578 (regulation of ATP metabolic process)
would be more appropriate.
proposed_replacement_terms:
- id: GO:1905707
label: negative regulation of mitochondrial ATP synthesis coupled proton transport
# ============================================================
# NEW annotations suggested based on literature review
# ============================================================
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: IDA
original_reference_id: PMID:12110673
review:
summary: >-
The mature IF1 protein functions in the mitochondrial matrix, where
it binds the F1 catalytic domain on the matrix-facing side of the
inner membrane. While "mitochondrion" is annotated, the more specific
sub-compartment (mitochondrial matrix) is not explicitly annotated.
UniProt states: "Mitochondrion" as subcellular location, and the
deep research notes that IF1 acts "on the matrix side of the F1
catalytic domain." Cryo-EM structures (PDB: 8H9E, 8H9L, 8H9S,
8H9U, 8KI3) place IF1 bound to the F1 domain which projects into
the matrix.
action: NEW
reason: >-
The mitochondrial matrix is the specific sub-compartment where
IF1 is active. The F1 domain that IF1 binds faces the matrix.
This more specific CC annotation is supported by structural data
and functional characterization. While "mitochondrion" is annotated,
the matrix localization should be explicitly noted.
supported_by:
- reference_id: PMID:12110673
supporting_text: "IF(1) could be co-isolated with F(1)F(0) when the immunocapture procedure was carried out at pH 6.5"
core_functions:
- molecular_function:
id: GO:0042030
label: ATPase inhibitor activity
directly_involved_in:
- id: GO:1905707
label: negative regulation of mitochondrial ATP synthesis coupled proton transport
- id: GO:0051882
label: mitochondrial depolarization
locations:
- id: GO:0005759
label: mitochondrial matrix
description: >-
The primary molecular function of ATP5IF1 is ATPase inhibitor activity. IF1
reversibly inhibits the ATP hydrolase activity of the F1Fo-ATP synthase (complex V)
by binding the alpha/beta catalytic interface and the gamma subunit of the F1 domain.
This prevents wasteful ATP consumption when the mitochondrial membrane potential
collapses during ischemia, hypoxia, or uncoupling. IF1 is active as an antiparallel
dimer at acidic pH (<6.7) and inactive as a tetramer at neutral pH. Phosphorylation
at Ser39 by a mitochondrial PKA-like activity inactivates IF1.
supported_by:
- reference_id: PMID:12110673
supporting_text: "Immunocaptured F(1)F(0) lacking IF(1) could be inhibited by more than 90% by addition of recombinant inhibitor protein, and conversely, F(1)F(0) containing IF(1) could be activated more than 10-fold by brief exposure to pH 8.0, inducing the release of inhibitor protein"
- reference_id: PMID:15528193
supporting_text: "IF1 protein bound to purified F(1) ATP synthase and inhibited F(1)-dependent ATP hydrolysis consistent with its reported activity in studies of mitochondria"
- reference_id: file:human/ATP5IF1/ATP5IF1-deep-research-falcon.md
supporting_text: "IF1 prevents ATP wastage by inhibiting ATP hydrolysis during conditions of low proton motive force (e.g., ischemia/hypoxia), and, depending on cell type and regulation, can also inhibit forward ATP synthesis"
- molecular_function:
id: GO:0140260
label: mitochondrial proton-transporting ATP synthase complex binding
locations:
- id: GO:0005759
label: mitochondrial matrix
description: >-
IF1 directly binds the F1Fo-ATP synthase complex in a pH-dependent manner.
At acidic pH (6.5), IF1 co-purifies with the complex; at pH 8.0, IF1 is released.
The N-terminal inhibitory region (residues 26-52) contacts the alpha/beta subunit
interface and the gamma subunit. This binding is the mechanistic basis for the
ATPase inhibitor activity.
supported_by:
- reference_id: PMID:12110673
supporting_text: "IF(1) could be co-isolated with F(1)F(0) when the immunocapture procedure was carried out at pH 6.5 but was absent when the ATP synthase was isolated at pH 8.0"
references:
- id: GO_REF:0000002
title: Gene Ontology annotation through association of InterPro records with GO
terms
findings: []
- id: GO_REF:0000024
title: Manual transfer of experimentally-verified manual GO annotation data to orthologs
by curator judgment of sequence similarity
findings: []
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000052
title: Gene Ontology annotation based on curation of immunofluorescence data
findings: []
- id: GO_REF:0000107
title: Automatic transfer of experimentally verified manual GO annotation data to
orthologs using Ensembl Compara
findings: []
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods
findings: []
- id: file:human/ATP5IF1/ATP5IF1-deep-research-falcon.md
title: Deep research review of ATP5IF1 gene function (Falcon provider)
findings:
- statement: >-
ATP5IF1 encodes mitochondrial ATPase inhibitory factor 1, a reversible
pH-sensitive inhibitor of F1Fo-ATP synthase that prevents ATP hydrolysis
under low proton motive force conditions.
supporting_text: >-
IF1 is a reversible, pH-sensitive inhibitor that primarily prevents
wasteful ATP hydrolysis when Δψm collapses, but can also inhibit ATP
synthesis in some contexts
- id: PMID:10664857
title: Nucleotide sequence of cDNA coding the mitochondrial precursor protein of
the ATPase inhibitor from humans.
findings:
- statement: Cloned and sequenced the human IF1 cDNA encoding a 106 amino acid precursor protein
supporting_text: "The deduced protein sequence shows that the protein was composed of 106 amino acids and had a molecular weight of 12248"
- statement: Identified the protein as the human homolog of the bovine ATPase inhibitor
supporting_text: "cDNA coding the human homolog of the inhibitor protein was isolated and sequenced"
- id: PMID:12110673
title: A functionally active human F1F0 ATPase can be purified by immunocapture
from heart tissue and fibroblast cell lines. Subunit structure and activity studies.
findings:
- statement: IF1 co-purifies with F1Fo-ATP synthase at pH 6.5 but not at pH 8.0
supporting_text: "IF(1) could be co-isolated with F(1)F(0) when the immunocapture procedure was carried out at pH 6.5 but was absent when the ATP synthase was isolated at pH 8.0"
- statement: Recombinant IF1 inhibits ATP hydrolysis by >90%
supporting_text: "Immunocaptured F(1)F(0) lacking IF(1) could be inhibited by more than 90% by addition of recombinant inhibitor protein"
- statement: IF1 release at pH 8.0 activates ATP hydrolysis >10-fold
supporting_text: "F(1)F(0) containing IF(1) could be activated more than 10-fold by brief exposure to pH 8.0, inducing the release of inhibitor protein"
- statement: IF1 detected by specific antibody in immunocaptured complex from heart mitochondria
supporting_text: "The immunoprecipitated F(1)F(0) contained a full complement of subunits that were identified with specific antibodies against five of the subunits (alpha, beta, OSCP, d, and IF(1))"
- id: PMID:15528193
title: An Inhibitor of the F1 subunit of ATP synthase (IF1) modulates the activity
of angiostatin on the endothelial cell surface.
findings:
- statement: IF1 binds purified F1-ATP synthase and inhibits ATP hydrolysis
supporting_text: "IF1 protein bound to purified F(1) ATP synthase and inhibited F(1)-dependent ATP hydrolysis consistent with its reported activity in studies of mitochondria"
- statement: IF1 inhibits ATP hydrolysis but not ATP synthesis on cell surface
supporting_text: "IF1 inhibited ATP hydrolysis but not ATP synthesis, in contrast to angiostatin, which inhibited both"
- statement: IF1 only slightly inhibits endothelial cell proliferation
supporting_text: "IF1 did not inhibit EC differentiation to form tubes and only slightly inhibited cell proliferation compared with angiostatin"
- statement: IF1 is not an angiostatin mimetic
supporting_text: "We propose that IF1 is not an angiostatin mimetic, but it can serve a protective role for EC in the tumor microenvironment"
- statement: Angiostatin blocks IF1 binding to ATP synthase
supporting_text: "angiostatin blocks IF1 binding to ATP synthase and abolishes its ability to conserve ATP"
- id: PMID:20833797
title: Phosphoproteome analysis of functional mitochondria isolated from resting
human muscle reveals extensive phosphorylation of inner membrane protein complexes
and enzymes.
findings:
- statement: IF1 detected in mitochondrial phosphoproteome from human skeletal muscle
supporting_text: "We performed a phosphoproteomics study of functional mitochondria isolated from human muscle biopsies"
- id: PMID:21106936
title: Regenerative protein thymosin beta-4 is a novel regulator of purinergic signaling.
findings:
- statement: IF1 shares amphiphilic alpha-helical structural similarities with beta-thymosins
supporting_text: "in silico we identified common amphiphilic α-helical structural similarities between β-thymosins and the inhibitory factor 1 (IF1), an inhibitor of ATP synthase hydrolysis"
- statement: IF1 is an inhibitor of ATP synthase hydrolysis
supporting_text: "the inhibitory factor 1 (IF1), an inhibitor of ATP synthase hydrolysis"
- id: PMID:23135403
title: Mitochondrial Atpif1 regulates haem synthesis in developing erythroblasts.
findings:
- statement: Atpif1 regulates heme synthesis by modulating mitochondrial pH and redox potential
supporting_text: "Atpif1 modulates the mitochondrial pH and redox potential, and thus allows Fech to efficiently catalyze the incorporation of iron into PPIX to produce heme"
- statement: Required for FECH to catalyze iron incorporation into protoporphyrin IX
supporting_text: "Loss of Atpif1 allows the mitochondrial pH and, consequently, the redox potential to change to a level that reduces [2Fe-2S] cluster-containing Fech activity, thereby reducing heme synthesis"
- id: PMID:24005319
title: Genome-wide RNAi screen identifies ATPase inhibitory factor 1 (ATPIF1) as
essential for PARK2 recruitment and mitophagy.
findings:
- statement: ATPIF1 is essential for PARK2 translocation to mitochondria
supporting_text: "we identified ATPase inhibitory factor 1 (ATPIF1/IF1) as essential for PARK2 recruitment and mitophagy in cultured cells"
- statement: ATPIF1 promotes mitochondrial depolarization during uncoupling
supporting_text: "During uncoupling, ATPIF1 promotes collapse of ΔΨ and activation of the PINK-PARK2 mitophagy pathway by blocking the ATPase activity of the F 1-Fo ATP synthase"
- statement: ATPIF1 blocks ATPase activity of F1-Fo ATP synthase
supporting_text: "blocking the ATPase activity of the F 1-Fo ATP synthase"
- statement: Restoration of ATPIF1 in Rho0 cells lowers membrane potential and triggers PARK2 recruitment
supporting_text: "Restoration of ATPIF1 in Rho0 cells, which lack mtDNA and a functional electron transport chain, lowers ΔΨ and triggers PARK2 recruitment"
- id: PMID:28514442
title: Architecture of the human interactome defines protein communities and disease
networks.
findings:
- statement: ATP5IF1 interacts with ATP5F1B (P06576) in BioPlex 2.0 interactome
- id: PMID:30021884
title: Histone Interaction Landscapes Visualized by Crosslinking Mass Spectrometry
in Intact Cell Nuclei.
findings:
- statement: ATP5IF1 crosslinked to ATP5F1B (P06576) detected in nuclear preparations
- id: PMID:32296183
title: A reference map of the human binary protein interactome.
findings:
- statement: ATP5IF1 detected interacting with KIF9 and PICK1 in HuRI Y2H screen
- id: PMID:32807793
title: OSMR controls glioma stem cell respiration and confers resistance of glioblastoma
to ionizing radiation.
findings:
- statement: OSMR detected interacting with ATP5IF1 in mitochondrial context
- id: PMID:32814053
title: Interactome Mapping Provides a Network of Neurodegenerative Disease Proteins
and Uncovers Widespread Protein Aggregation in Affected Brains.
findings:
- statement: ATP5IF1 detected as interactor of multiple neurodegenerative disease proteins in Y2H screen
- id: PMID:33961781
title: Dual proteome-scale networks reveal cell-specific remodeling of the human
interactome.
findings:
- statement: ATP5IF1 interacts with ATP5F1B (P06576) in BioPlex 3.0 interactome
- id: PMID:34800366
title: Quantitative high-confidence human mitochondrial proteome and its dynamics
in cellular context.
findings:
- statement: ATP5IF1 identified as a high-confidence mitochondrial protein
- id: PMID:35926043
title: Mitochondrial remodeling and ischemic protection by G protein-coupled receptor
35 agonists.
findings:
- statement: GPR35 binds ATPIF1 at the outer mitochondrial membrane
supporting_text: "GPR35 activated Gi- and G12/13-coupled signaling and trafficked to the outer mitochondria membrane, where it bound, apparantly indirectly, to ATP synthase inhibitory factor subunit 1 (ATPIF1)"
- statement: ATPIF1-dependent ATP synthase dimerization prevents ATP loss during ischemia
supporting_text: "Activated GPR35, in an ATPIF1-dependent and pertussis toxin-sensitive manner, induced ATP synthase dimerization, which prevented ATP loss upon ischemia"
- statement: Activated GPR35 in pertussis toxin-sensitive manner induces ATP synthase dimerization
supporting_text: "Activated GPR35, in an ATPIF1-dependent and pertussis toxin-sensitive manner, induced ATP synthase dimerization"
- id: PMID:40205054
title: Multimodal cell maps as a foundation for structural and functional genomics.
findings:
- statement: ATP5IF1 interacts with ATP5F1B (P06576) in multimodal cell maps